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Abstract
Stem cell factor (SCF) is a growth factor, essential for haemopoiesis, mast cell development and melanogenesis. In the
hematopoietic microenvironment (HM), SCF is produced either as a membrane-bound (2) or soluble (+) forms. Skin
expression of SCF stimulates melanocyte migration, proliferation, differentiation, and survival. We report for the first time,
a novel mRNA splice variant of SCF from the skin of white merino sheep via cloning and sequencing. Reverse transcriptase
(RT)-PCR and molecular prediction revealed two different cDNA products of SCF. Full-length cDNA libraries were enriched by
the method of rapid amplification of cDNA ends (RACE-PCR). Nucleotide sequencing and molecular prediction revealed that
the primary 1519 base pair (bp) cDNA encodes a precursor protein of 274 amino acids (aa), commonly known as ‘soluble’
isoform. In contrast, the shorter (835 and/or 725 bp) cDNA was found to be a ‘novel’ mRNA splice variant. It contains an
open reading frame (ORF) corresponding to a truncated protein of 181 aa (vs 245 aa) with an unique C-terminus lacking the
primary proteolytic segment (28 aa) right after the D
175G site which is necessary to produce ‘soluble’ form of SCF. This
alternative splice (AS) variant was explained by the complete nucleotide sequencing of splice junction covering exon 5-
intron (5)-exon 6 (948 bp) with a premature termination codon (PTC) whereby exons 6 to 9/10 are skipped (Cassette Exon,
CE 6–9/10). We also demonstrated that the Northern blot analysis at transcript level is mediated via an intron-5 splicing
event. Our data refine the structure of SCF gene; clarify the presence (+) and/or absence (2) of primary proteolytic-cleavage
site specific SCF splice variants. This work provides a basis for understanding the functional role and regulation of SCF in hair
follicle melanogenesis in sheep beyond what was known in mice, humans and other mammals.
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Introduction
Many growth factors such as colony-stimulating factor-1 (CSF),
transforming growth factor- a (TGF-a), and tumor necrosis factor
(TNF) occur in both membrane-bound and secreted forms [1] by
specific proteolytic cleavages. These growth factors and their
receptors play vital roles in normal development as mediators of
intercellular communication by diffusible molecules and often
promote cell differentiation and maturation. Stem cell factor (SCF)
[2] also known as steel factor (SLF or SF) [1,3]; mast cell growth
factor (MGF) [4,5]; kit ligand (Kitl, KL or KITLG) [6] is one of
several pleiotropic growth factors, a cytokine that binds to its
cognate c-KIT receptor or stem cell factor receptor (SCFR) [2],
the product of the c-kit gene. SCF is encoded by the murine Steel
(Sl) locus while KIT is encoded by dominant white spotting (W) KIT
locus in the mouse [7,8]. SCF plays an important role in
hematopoiesis, spermatogenesis, and melanogenesis [1]. In the
hematopoietic microenvironment (HM), SCF is produced either as
a membrane-bound or soluble form [9,10].
SCF is produced as transmembrane proteins that are released
by specific proteolytic cleavage to generate soluble factors [3,5,11].
Alteration in the balance between the diffusible and membrane-
bound forms may lead to phenotypic abnormalities as previously
reported in dominant white spotting (W) or the Steel (Sl) loci which are
among the most studied mutations in mouse [7,8,12–15].
Investigations into the expression of c-KIT and SCF in the skin
during melanocyte migration are consistent with the known W and
Sl phenotypes and suggest that SCF mediates a chemotactic/
hapatotactic signal for c-kit in the development of pigmentation
[6]. The membrane-bound SCF/c-KIT signalling could act on
mammalian hair follicle melanogenesis during cyclic anagen
phases, resulting in hair follicle pigmentation [16]. Besides its role
as a melanocyte survival factor, SCF can also act synergistically
with several interleukins and granulocyte-macrophage-colony
stimulating factor to enhance UV-induced pigmentation [17,18].
The signalling of SCF and its receptor c-KIT has been
documented to regulate essential roles in the maintenance of
embryonic melanocyte lineages and postnatal cutaneous melano-
genesis [3,19–21].
Alternative Splicing (AS) is a key element in gene regulation that
increases proteome diversity and the coding potential of various
eukaryotic genomes. Evidence from expressed sequence tags
(ESTs), cDNA, genome-wide Tilling and splicing microarray
datasets in human demonstrate that alternative splicing occurs in
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590% of genes [22,23]. The high incidence of AS in the
pigmentation gene network for example SCF/c-KIT [14,16]
and MITF [24] might contribute to the regulation of their switch
in the development of various genetic disorders and phenotypic
abnormalities. In the case of SCF gene, AS results in two
membrane-bound protein products [5,6,25]. To date, two
alternatively spliced forms of SCF mRNA have been reported in
the mouse: 1) the full-length form; and 2) an alternative form
lacking exon 6, which like the corresponding human transcript,
produces a 28 aa deletion. Exon 6 codes for an extracellular
cleavage site, which is susceptible to proteolytic cleavage by
proteases. Expression of the SCF variant containing this exon 6
will produce a membrane-bound isoform, designated as SCF-1
(KL-1) or (+) form, and its proteolytic cleavage will generate
a soluble form of the factor. In contrast, expression of the SCF
splice variant, lacking exon 6, gives rise to a stringent membrane-
bound protein, known as SCF-2 (KL-2) or (2) form [5,6,11,25].
The SCF expression ratio between the KL-1 and KL-2 isoforms
varies significantly between various cell types [6,11]. A Mouse
mutagenesis study [10] reported the usage of secondary cleavage
site in the absence of primary cleavage site (exon 6) to generate the






Three isoforms have been identified and documented for
human and mouse SCF genes (source: GenBank, NCBI, http://
www.ncbi.nlm.nih.gov/; Ensembl, www.ensembl.org/; UniProt,
www.uniprot.org/). Basically, the first two isoforms (273 aa and
245 aa) differ by the presence (+) and absence (2) of potential
primary proteolytic site (exon 6), respectively. The third, shortest
isoform (238 aa) differ in its N-terminus for the first 8 aa vs first
43 aa of the (+) and (2) form but has the primary proteolytic site.
In sheep, there exists only two partial mRNA records, the
counterparts of SCF-1 (+ form), one from ovarian follicle (780 bp,
Acc. No. U89874.1), the other in keratinocyte (622 bp, Acc. No.
Z50743.1) and two partial records of SCF genomic DNA
sequences i.e., a 59 UTR and partial CDS sequence (358 bp,
Acc. No. HM347344.1), the stem cell factor MGF25 (781 bp, Acc.
No. AF165788.1) gene, coding region not determined. The larger
mRNA species of SCF encodes a protein (Uniprot, P79368) of 267
amino acids (aa), known as ‘soluble’ isoform (SCF-1/b), which is
a transmembrane protein comprising of a 25 aa leader signal
peptide sequence, a 189 aa extracellular domain that includes
a proteolytic cleavage site (28 aa), followed by a hydrophobic
membrane spanning helical region (21–23 aa) and a short
cytoplasmic tail (36–37 aa) [5,6,25]. The alternative SCF mRNA
lacks exon 6, a deletion of 84 bp. This shorter mRNA species gives
rise to a protein, known as ‘membrane-bound’ isoform (SCF-2/a)
that lacks 28 aa, including one of the four N-linked glycosylation
sites in the C-terminus (Ala
164 and Ala
165) of the soluble SCF, as
well as the protease recognition site. This shorter form of the
protein yields soluble SCF less efficiently than the longer form of
the transmembrane protein. Hence the regulation of the
abundance of the alternatively spliced messages might significantly
contribute to the regulation of the production of soluble and/or
membrane-associated SCF by the cell [26]. The physiologic roles
of these SCF proteins remain uncertain. Notably, the biological
effects of the membrane-bound (as opposed to soluble) forms of the
protein may be significantly different, at least with respect to bone
marrow progenitor cells [9].
Numerous pigmentation mutants are phenotypically (.800
alleles) profound, but remain mechanistically uncharacterized
[27]. In sheep, the candidate genes for recessive black (ASIP)
[28,29], dominat black (MC1R) [30,31] and Brown (tyrosinase
related protein-1, TYRP1) [32] have been found which are known to
influence pigmentation or pigment synthesis level. In the merino
experimental models [33], authors proposed that ‘‘The inheritance of
white coat colour in merino sheep is dependent on single gene segregation,
without any modifying effects and is completely dominant over pigmented
animals’’. According to their data, Agouti (A) locus or extension (E
D)
locus [28–31] which are encoded by agouti signalling peptide (ASIP)
and the melanocortin-1 receptor (MC1R) loci respectively [34] have
never been associated with spotting or white in mammals. They
are involved, in fact, in melanin switching [13,35,36]. White can
be caused by defects at various stages of melanocytes development,
including proliferation, survival, migration, invasion of the in-
tegument, hair follicle entry and melanocytes stem cell renewal
[36]. Many white spotting traits have been identified in mouse and
man, and 10 of the genes have been cloned [36]. It has been
hypothesized that the gene for white phenotype in merino sheep is
on these loci [33]. Among those, for the loci microphthalmia-associated
transcription factor (MITF, microphthalmia) [37], c-KIT (Dominant
White Spotting) and SCF (Steel), it is possible to obtain completely
white live animals [27,36,38]. Since c-KIT/SCF signaling and
MITF-dependent transcription are both essential for the melano-
cyte development and pigmentation [39].
The study of genes controlling coat colour and pigmented fibres
are most relevant to ‘white’ wool production as brown or black
wool will not dye as readily. Since natural coloured fibre is a new
opportunity for textile industries, development of valid genetic
tools (coat colour tests) and effective sheep breeding programme
should go hand-in-hand to help breeders and small scale farmers
to reduce future occurrences with the wool market. The present
empirical study was undertaken as part of the huge in-house
project evaluating the involvement of three candidate genes such
as MITF, c-KIT and SCF in various coat colour traits of merino
sheep especially the white phenotype. Isolation of these genes and
knowledge of their structure will allow for further studies into the
regulation of gene expression in the ovine melanocyte biology and
skin pigmentation. In an effort, to better characterize the mRNA/
cDNA structure of SCF in the skin of white merino sheep we
performed cDNA cloning, sequencing and gene expression
analysis by semi-quantitative RT-PCR and Northern blot. In this
study, we isolated a novel mRNA splice variant from skin
designated as ‘SCF truncated isoform-2a/b (2)’, demonstrating for
the first time, that a premature stop codon (PTC) at the short 39
UTR sequence corresponding to intron 5 is due to the usage of an
alternative splice donor/acceptor site. The other ovine transcript
variant, ‘SCF isofrom-1 (+)’ expressed in skin, the commonly known
homolog of SCF (+) isoform in other mammals is also been
presented here. We also demonstrated that the relative gene
expression at mRNA transcript level is mediated via an intron 5
splicing event by Northern blot analysis. Further, this manuscript
discusses extensively on ovine SCF mRNA structural coverage,
putative AS events on the intron-5 of the SCF gene, mRNA and
protein structure domain characterization, homology modelling,
and molecular phylogeny of SCF.
Materials and Methods
Collection of Skin Biopsies and Blood
Skin biopsies were collected from uncoloured (white) and
coloured (black and brown) animals of the merino sheep using
disposable, sterile, biopsy punch (8 mm diameter), treated and
stored in RNAlater (Sigma-Aldrich, Milan, Italy), transferred to
the molecular biology laboratory and immediately frozen in liquid
nitrogen until RNA extraction. Blood samples were collected from
the jugular vein of the same individuals with PAXgene Blood
DNA Tubes (PreAnalytix kit, Qiagen, Milan, Italy) via standard
Alternative Splicing of the Sheep SCF Gene
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ing to the manufacturer’s protocol for the DNA isolation and the
aliquotes were stored at -80
oC. Samples were collected and
recorded according to the farm technicians from Aziende la
Campana Montefiore dell’Aso (Ascoli Piceno, Marche), La
Meridiana Umbertide (Perugia, Umbria), Italy with permission
from the owners of each farm.
RNA and DNA Isolation and Quantification
Total RNAs were extracted from the stored skin biopsies of all
three animals using TRI Reagent (Sigma-Aldrich, Milan, Italy)
according to the manufacturer’s instructions followed by treatment
with RNase-free DNase (Fermentas, Milan, Italy) to remove
contaminated DNAs. Tissue was homogenized (0.075 g in 750 ml
TRI reagent) using Polytron homogenizer (Qiagen, Milan, Italy).
Genomic DNAs were isolated from the blood samples with
PAXgene Blood DNA kit (PreAnalytix kit, Qiagen, Milan, Italy)
following the given handbook protocol.
The qualitative assessment of the isolated, purified DNAs,
RNAs were done utilizing the Genesys 10 UV Spectrophotometer
(Thermo Electron Corporation, Madison, USA). The purity was
assessed by calculating the ratio of optical density (OD) at A260/
A280 and the integrity was determined by running the samples on
1.0% formaldehyde-agarose gel electrophoresis for RNA and
0.8% agarose gel electrophoresis for DNA [40]. For DNA, the
concentration was also evaluated based on the intensities of band
with reference to the molecular weight standard Lambda (l) DNA
EcoRI HindIII digest (Fermentas, Milan, Italy) or 1 kb gene ruler
(USB Corporation, Cleveland, USA). The nucleic acid concen-
tration was calculated following [40] and the DNA samples were
diluted to 10 ng/ml or 50 ng/ml for PCR amplification.
cDNA Synthesis and RT-PCR Amplification
cDNAs were synthesized from total RNA extracted from the
skin of the merino sheep. Reverse Transcription (RT) from 1–
1.5 mg of RNA in a toal volume of 20 ml containing 50 pmol
oligo(dT) (18-mer) or oligo(dT)18 modified primer, 0.5 mM
deoxyribonucleoside triphosphate (dNTPs), 16RT buffer, 20 U
of RNase inhibitor and 200 U PrimScript
TM Reverse Transcrip-
tase (Takara Bio Inc., Clontech, Jesi, Italy) or StrataScript
TM
Reverse Transcriptase (Stratagene, Agilent Technologies, Milan,
Italy) according to the manufacturer’s instructions. The reaction
was incubated for 60 min at 42uC and then heated at 70uC for
15 min, and cooled on ice. All the RT reactions were performed in
a Perkin-Elmer Cetus Model 480 DNA Thermal Cycler (Perkin-
Elmer, Monza, Italy) and/or MyCycler
TM Thermal Cycler (Bio-
Rad Laboratories, Segrate, Italy). Subsequently, 0.5–0.7 ml of the
first strand cDNA reaction was used for PCR amplification. The
reactions were performed in 25 ml volume containing 16PCR
bufffer, 1.5 mM MgCl2, 2.0 mM dNTPs, 0.3–0.5 mM gene
specific primers (Table S2), 20–30 ng/ul cDNA and 1.5 U of
proofreading Easy-A High-Fidelity PCR Cloning Enzyme (Stra-
tagene, Agilent Technologies, Milan, Italy) and the cDNA check
amplification was performed with Dream Taq DNA polymerase
(Fermentas, Milan, Italy). Three-step RT-PCR amplification was
performed in a MyCycler
TM Thermal Cycler (Bio-Rad Labora-
tories, Segrate, Italy), TGRADIENT Thermocycler (Biometra
GmbH, Go ¨ttingen, Germany) with an initial denaturation at 95uC
for 3 min, followed by 5 primary cycles of 94uC for 1 min,
annealing temperature (Ta
oC) below 3–5uC of the temperature
melting (Tm) of the gene specific primer whichever is lowest of the
two primers for 1 min, and a 72uC for 1 min. This was then
followed by 25 consecutive cycles of 94uC for 15–30 sec, annealing
temperature (Ta
oC) for 15–30 sec and 72uC for 20–30 sec with
a final extension at 72uC for 10 min, lastly a hold temperature at
4uC. NOTE: PCR cycling conditions especially Ta, timing
interval varies with primer sets and the expected size of amplicons
(see Table S2 for details).
The isoform (+) specific primer pair for the the amplification of
the open reading frame (ORF) corresponding to the 621 bp of the
sheep SCF cDNA was designed based on the coding sequence
homology among human (GenBank Acc. No. NM_000899.3),
chimpanzee (XM_509255.2), marmoset (XM_002752832.1),
orangutan (XM_002823566.1), mouse (NM_013598.2), rat
(NM_021843.3), panda (XM_002921694.1), cat
(NM_001009343.1), horse (NM_001163962.1), dog
(NM_001012735.1), goat (AB002152.1), pig (NM_214269.2),
cow (NM_174375.2) and sheep (GU386372) using Primer3
software [41]. The remaining 59 and 39 RACE SCF gene specific
primer pairs were deduced from the 621 bp cDNA coding
sequence (CDS) fragment to walk up and down in order obtain the
full-length cDNAs. All the designed primer pairs were checked
with the online software tools [42,43] before making an order with
[42]. The primers used in this study were synthesized and
purchased from Sigma-Aldrich, Milan, Italy.
Rapid Amplification of cDNA end Experiments (59 and 39
RACEs)
We performed 59 and 39 RACE experiments to isolate and
determine the sheep full-length SCF cDNA(s). This was done
following the instructions of 59 (v. 2.0) and 39 (v. E) RACE System
for Rapid Amplification of cDNA Ends (Invitrogen, Life
Technologies, Monza, Italy).
59 RACE cDNAs were reverse transcribed from 1–1.5 mgo f
RNA in a total volume of 20 ml containing 2–2.5 pmol SCF gene
specific splice variant primers (Table S2), 0.5 mM dNTPs, 16RT
buffer, 20 U of RNase inhibitor, 200 U of PrimScript
TM Reverse
Transcriptase (Takara Bio Inc., Clontech, Jesi, Italy) and
StrataScript
TM Reverse Transcriptase (Stratagene, Agilent Tech-
nologies, Milan, Italy) according to the manufacturer’s instruc-
tions. The reaction was incubated for 60 min at 50uC and then
heated at 70uC for 15 min, cooled on ice and stored at 220uC.
Two different 59 RACE cDNAs were synthesied with gene specific
primer for the SCF (+) and (2) form (see Table S2 for details). This
was then followed by 0.1 volume of 3 M sodium acetate, pH 4.8
or 5.2 salt and 2.5 volume of 100% ethanol preicipitation to the
final volume of 100 ml5 9 RACE cDNA. The precipitation was
carried out at 280uC over night and centifuged twice at 16,000 g
for 30 min. The pellet was washed twice with 70% ethanol at
16,000 g for 15 min. The collected, air dried pellet was finally
dissolved in 40 ml DEPC treated water and stored as aliquotes at
280uC. A homopolymeric tail was then added to the 39-end of the
purified cDNA (10 ml) using 30 U terminal deoxynucleotidyl
transferase (TdT, USB Corporation, Cleveland, USA and
Invitrogen, Life Technologies, Monza, Italy) and 0.2 mM dCTP
(Fermentas, Milan, Italy) following the protocol of 59 RACE
System (v. 2.0, Invitrogen, Life Technologies, Monza, Italy). The
reaction was incubated at 95uC for 3 min for the denaturation and
37uC for 12 min for the addition and then heat inactivated at
70uC for 10 min, cooled on ice and stored at 220uC. Sub-
sequently, 3 ml of the dC-tailed cDNA was used in a final volume
of 50 ml for the first round enrichment PCR amplification followed
by second round nested amplification using 2–3 ml of the primary
enriched RT-PCR reaction. The primer combinations used were
adapter forward primers aapfwd (first round), auapfwdnst (second
round, nested) and scfrev1 (proteolytic site, + form, first round),
scfrev2 (common region, - form, first round) and scfrev3 (common,
second round) as the reverse primers, respectively. NOTE:
Alternative Splicing of the Sheep SCF Gene
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RACE kit, Invitrogen, Life Technologies, Monza, Italy and
synthesised by Sigma-Aldrich, Milan, Italy. The PCR amplifica-
tion was carried out as described above for 36 cycles and the
cycling conditions especially Ta, timing interval varies with 59
RACE primer sets and the expected size of amplicons (see Table
S2 for details).
First strand 39 RACE cDNAs were prepared with a high Tm
oligo(dT)18 modified primer as described above and 1 ml of this
cDNA was used in a final volume of 50 ml for the first round PCR
amplification. Successive nested, splice variant specific amplifica-
tions were performed in a 50 ml PCR volume using 1 ml of the
primary enriched RT-PCR reaction.
The PCR was run for 36 cycles as described above and the
cycling conditions especially Ta, timing interval varies with specific
59 and 39 RACE primer sets (see Table S2 for details). For 39
RACE the primer pairs having high Tm were subjected to a two-
step PCR with a coupled annealing, extension at 69 or 72uC for
3 min 10 sec up to 10 min. The primer combinations used for
distinctive 59 and 39 RACE amplification and the expected size of
amplicons were presented in Table S2. NOTE: Forward adapter
primer sequences were retrieved from the 59 RACE kit,
Invitrogen, Life Technologies, Monza, Italy and synthesised by
Sigma-Aldrich, Milan, Italy.
DNA Splice Junction Amplification
Blood genomic DNA was amplified to confirm the splice site
premature termination with a poly A signal detected on sheep SCF
cDNA transcripts. The Expand Long Range, dNTPack (Roche
S.p.A., Milan, Italy) was used following the manufacturer’s
instructions, including 0.3–0.5 mM specific primers scffwd3 (exon
5, common) and scfrev1 (exon 6, + form specific) (Table S2),
500 mM dNTP mix, 3% DMSO, 100–150 ng of genomic DNA
and 3.5 U of Expand Long Range Enzyme mix in a final 50 ml
PCR volume. The PCR protocol was performed as per Roche’s kit
protocol. Since the available unfinished draft reference sheep
genome, Oarv2.0 (current version, March 2011 - till date, http://
www.livestockgenomics.csiro.au/sheep/oar2.0.php) did not pro-
vide much information regarding the SCF gene, the reference SCF
genomic locus at the exon 5-intron (5)-exon 6 splice junction was
covered in comparison to the orthologous SCF gene assembly of
human, mouse, cow and dog.
Expression of Ovine SCF in Skin
To determine the relative abundance of the SCF (+) and (2)
cDNA transcripts, we performed semi-quantitative RT-PCR
amplification using two different sets of splice variant specific (+
and -) primers as summarised in Table S2. Four sets of primer
pair included (+) form specific forward (exon 5-exon 6:
stpro3’Rfwd1), reverse primer (exon 6: scfrev1); the common
forward primers (scffwd1, scffwd4) located on the common
region of the CDS and a (2) form specific reverse primer
(scf(2)rev) which was designed spanning into the exon 7-exon 5
splice junction. Total RNA of 1.5 mg of each animal (white,
black, brown) was reverse transcribed into cDNA using 200 U
PrimScriptTM Reverse Transcriptase (Takara Bio Inc., Clon-
tech, Jesi, Italy) and 50 pmol oligo(dT) modified primer in
a2 0ml reaction volume, as described above. PCR amplification
was performed using 0.5 ml of the each cDNA sample as
a template in 25 ml of a reaction mixture consisting of
16DreamTaq buffer, 1.5 mM MgCl2, 0.2 mM dNTPs,
0.5 mM each of primer and 1.5 U of DreamTaq DNA
polymerase (Fermentas, Milan, Italy). After an initial denatur-
ation step of 3 min at 95uC, a 3-step PCR programme was
carried out with 5 successive cycles of 25 sec at 95uC for
denaturation, 25 sec at primer-specific annealing temperature
(TauC) for annealing procedure and 25 sec at 72uC for
extension, followed by 25 repeat cycles of 94uC for 15 sec,
annealing temperature (Ta
oC, see Table S2) for 15 sec and
72uC for 20 sec with a final extension at 72uC for 10 min and
a cooling phase at 4uC. Amplified RT-PCR products were
separated on 1.5–2% agarose gel electrophoresis, and were
evaluated by ethidium bromide staining and UV transillumina-
tion. For the RT-PCR reference, constitutively expressed
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 252 bp)
and 18 S rRNA (132 bp) was used as an equal loading control.
The house keeping gene (HKGs) primers were designed from
the corresponding Ovis aries NCBI GenBank Accession Nos. (see
Table S2) and amplified with the same PCR conditions and
cycle numbers. Amplicons were confirmed by cloning and direct
sequencing. The relative signal strength was measured using the
QuantiScan Demo software [44].
For Northern blot analysis, total RNA was isolated from skin
as described above. The poly(A)+ mRNA from total RNA was
purified using Oligotex mRNA Midi Kit (Qiagen, Milan, Italy)
following the manufacturer’s protocol. The 40 ml eluted mRNA
sample was separated on a 1.2% denaturing formaldehyde-
agarose gel electrophoresis [40]. Subsequently, mRNA was
transferred to a Hybond
TM-N Neutral nylon membrane
(Amersham Biosciences, GE Healthcare Europe GmbH, Milan,
Italy) overnight by capillary diffusion [40]. The mRNA was
crosslinked onto the membrane by baking at 80uC for 2 h. The
membrane was pre-hybridized at 50uC for 1 h and then
hybridized overnight at 50uC containing denatured DIG-labeled
PCR probe (2 ml/ml). DIG-labeled PCR probes were synthe-
sized using a PCR DIG Probe Synthesis kit (Roche S.p.A.,
Milan, Italy). DIG labeled DNA fragments of ovine SCF
(222 bp, +/2 form) and 18 S rRNA (132 bp) were synthesized
by PCR using the corresponding cDNA clones as templates and
gene-specific primers (see Table S2). Following low (265 min
with 26SSC, 0.1% SDS at room temperature) and high
(2615 min with 0.16SSC, 0.1% SDS at 50uC) stringent washes,
the nylon membrane was incubated in the blocking solution for
45 min followed by additional incubation with a blocking
solution that contained a 1:5,000 dilution of alkaline phospha-
tase conjugated, anti-DIG antibody (Roche S.p.A., Milan, Italy)
and incubated for 15–45 min at room temperature. The
hybridized probe was detected with the chemiluminescent
substrate, CSPD (Roche S.p.A., Milan, Italy). Hybridization
signals were detected by exposure of the membrane to KodakH
BioMaxH XAR Film (Sigma, Milan, Italy) at room temperature.
Pre-hybridization, hybridization, blocking and washing solution
recipes were prepared and followed according to the procedures
for nonradioactive (DIG) labeling and detection of nucleic acids
(Roche S.p.A., Milan, Italy). Probes were stripped at 80uC for
2660 min before rehybridization according to the manufac-
ture’s instructions (DIG application manual, Roche S.p.A.,
Milan, Italy).
Gel Electrophoresis and Photography
Amplified products were subjected to 1.2–1.5% agarose gel
electrophoresis using 16TAE buffer (40 mM Tris-acetate, pH 8.0,
1 mM EDTA) at 5–7 V/cm. The gels were stained with 0.5 mg/
ml ethidium bromide, visualized on ultraviolet transilluminator
(Macrovue model 2011, LKB Produkter, Bromma, Sweden). Gels
were captured and analyzed using Kodak Digital Science DC40,
1D software for Electrophoresis Documentation and Analysis
System (Kodak, Rochester, New York, USA).
Alternative Splicing of the Sheep SCF Gene
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All the selected amplicons were gel purified either manually by
salt precipitation or using Nucleospin columns (Macherey-Nagel,
GmbH & Co. KG, Du ¨ren, Germany). Cloning was performed in
the TA cloning system (pGEMH-T Easy, Promega, Milan, Italy;
pCRH2.1 TOPO, Invitrogen, Life Technologies, Monza, Italy;
InsTAclone
TM, Fermentas, Milan, Italy and pSC-A, StrataClone-
UA, Stratagene, Agilent Technologies, Milan, Italy). The ligated
products (3–5 ml) were transfered by heat shock treatment into
a chemically competent DH5a cells which were prepared
manually [40], except for pSC-AStrataClone-UA vector system
for which StrataClone SoloPack competent cells were used
(included in the kit package). Clones were screened by M13
colony PCR amplification. Identified positive colonies were
inoculated into the selective antibiotic LB or SOB medium for
the over night culture at 37uC, 150 rpm in a shaker waterbath.
Subsequently, plasmid DNAs were isolated [40] and screened for
the release of expected insert(s) by analytical single or double
restriction enzyme digestion (EcoRI or EcoRI+HindIII) according
to the vector map. Positive clones were prepared for sequencing
and sequenced by the commercial vendors (StarSEQ, Mainz,
Germany; BMR sequencing, Padova, Italy) with M13 forward
and/or reverse primer or sequenced with any one of the gene
specific primer for deeper sequencing of the inserts whenever
necessary. Sequences were viewed with sequencing chromatogram
trace viewer FinchTV v. 1.4.0 [45].
Sequence Data
Our new sequenced data of SCF can be accesed through NCBI
GenBank accession nos. GU386371– GU386374 (Table S1).
mRNA Secondary Structure Analysis
We used the webserver program Mfold v. 3.5 [46] for predicting
the non-coding RNA (ncRNA) secondary structure stability of the
different SCF transcripts and its miRNA target binding sites. The
structure of DNA splice junction was analysed with DNA Folding
Form [46]. The ncRNA secondary structures were also predicted
with a set of MUSCLE [47] aligned mammalian homologous
sequences of the SCF cDNA transcripts using Sequences Selection
for the Comparative Approach (SSCA) by Tfold [48]. The optimal
secondary structures for all sequences were obtained in a dot-
bracket notation with minimum free energy and the structural
elements such as helices, internal and terminal loops were
deterrmined by drawing the RNA structure in the java applet
VARNA v. 3.7 [49]. All fold analyses were performed using the
default setting of the web servers.
The TargetScan program Release 5.1 [50] and miRBase
Release 16 [51] were used to locate potential sheep SCF 39 UTR
miRNA target sites from human, mouse, dog, cow and chicken.
Protein Homology Modelling
Protein templates were identified and scrutinized using Tem-
plate Identification tool at SWISSMODEL Workspace v 8.0.5
[52], Reverse PSI-BLAST (in BLAST 2.2.12 packages) search
against protein data bank (PDB) and Structural Classification of
Proteins (SCOP) at Genomes TO Protein structures and functions
(GTOP) [53].
The homology modeling was performed with Modeller 9v2 [54]
using an integrated multiple sequence alignment and multiple
structure visualization application ‘Friend’ v. 2.0 [55]. All the
modelled structures were stored as a PDB format data (.pdb) and
then viewed, edited with ViewerLite v. 5.0, Discovery Studio
Visualizer 2.5.5 [56]. Modelled structures were assessed with
Protein Structure and Model Assessment Tools at SWISSMO-
DEL Workspace. The secondary structures such as Alpha helix,
Beta strand, Beta bulge, 3,4,5-turns were defined with respective
colours using CCP4MG release 2.4.3 [57]. Homology modeling
was also attempted with an automated modeling server at
SWISSMODEL Workspace [52].
Sequence Analysis and Molecular Phylogeny
Whole mammalian genome scanning was done to identify the
homologous regions of sheep SCF cDNA transcript variants using
Basic Local Alignment Search Tool (BLAST) at National Center
for Biotechnology Information (NCBI), Bethesda, Maryland, USA
[58], ENSEMBL release 60 [59] and BLAT [60] searches,
sequentially. Sequences were edited, translated using the BioEdit
v.7.0.5.2 (Ibis Therapeutics, Carlsbad, CA, USA) [61] and
DNASTAR 7 [62] software packages. The open reading frame
(ORF) of the full-length SCF cDNAs was determined by
DNASTAR 7 [62] and ORF Finder at NCBI (www.ncbi.nlm.
nih.gov/gorf/). The positions of exons and introns were de-
termined and the translated SCF protein to genome structure was
drawn using WebScipio [63] in reference to the SCF gene
structure of human, mouse and dog. ClustalW2 [64] and
MUSCLE [47] programs were used to align the DNA and
protein sequences. Subsequently, Gblocks program [65] was used
to eliminate the poorly aligned positions and divergent regions on
the DNA and protein alignments for the phylogenetic analysis.
The datas were then converted to FASTA (.fas) and NEXUS (.nex)
formats using DataConvert (v. 1.0) [66].
Distance based neighbour-joining (NJ) phylogenetic trees were
generated using the Molecular Evolutionary Genetics Analysis
(MEGA) software v. 4.1 [67]. The NJ algorithm [68] was
implemented with the p-distance [69], Jukes-Cantor [70] and
Tamura-Nei [71,72] model using a transition+transversion sub-
stitution at uniform rates as well with the gamma parameter of 4.0.
The robustness of each phylogeny was assessed by percentage of
1000 bootstrap (BS) [73] re-samplings.
Phylogenetic relationships were inferred using Maximum
Likelihood (ML) method with the programs PhyML-aLRT (v.
2.4.5) [74], RAxML (v. 2.2.3) [75] using the java application
program TOPALi (v. 2.5) [76] and MrBayes (v 3.1.2) [77] for the
Bayesian Inference (BI) analyses. Among the 88 models tested, two
best models Hasegawa Kishino Yano (HKY) [78] plus gamma
(+G) distributed rate heterogeneity, General Time-Reversible
(GTR+G) [79] matrices for nucleotides and Jones Taylor
Thornton (JTT+G) [80] matrix for protein alignments were
chosen and subjected to ML analyses as described above. The
topology of the trees was inferred by running 1000 bootstrap
replicates and expressed as a percentage.
Bayesian Inference consisted of two independent Markov Chain
Monte Carlo (MCMC, mcmc nruns) runs of 100,000 (ngen) were
calculated with trees samples at every 10
th generation and with
a prior burn-in of 25% (sump burnin=2500; sumt burnin=2500)
i.e., the first 2500 sampled trees were discarded. BI was run with
GTR+G, HKY+G and a JTT+G substitution models under the
above set parameters for the nucleotide and amino acids
alignments, respectively.
Molecular phylogeny models were selected based on the Akaike
Information Criterion (AIC), Akaike Information Criterion corrected verion
(AICc), Bayesian Information Criterion (BIC) and/or log Likelihood (-lnL)
scores, implemented in jModeltest (v. 0.1.1) [81] for nucleotides
and ProtTest (v. 2.4) [82] for proteins. Models selection were also
performed and compared with TOPALi (v. 2.5) [76]. All the tree
files (NJ, ML, BI) were stored in Nexus (.nex) or New Hampshire
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1.3.1 software [83].
Use of other Computational Tools and Databases
Ovine SCF transcripts were searched on chr. 5 of the Bos
taurus (Btau_5.2, current release 2011) chromosomal map using
NCBI map Viewer [84]. The sequence similarity was visualized
with Circos table viewer [85]. The post-transcriptional associ-
ated regulatory elements located in the 59 and 39 untranslated
regions (UTRs) of the SCF cDNA transcripts were retrieved
from UTR databases (UTRdb or UTRSite) [86] using the
online tools UTRScan and UTRBlast. The graphical represen-
tation of SCF amino acid and nucleic acid multiple sequence
alignment was drawn by a sequence logo generator, WebLogo
(v. 2.8.2) [87]. SCF polyadenylation sites were predicted using
the polyADQ web server [88]. Alternative splicing pattern of
the ovine SCF transcripts with human, mouse reference
assembly were predicted using ACEVIEW [89] and Alternative
Splicing and Transcript Diversity (ASTD 1.1) [90]. The splice
site prediction such as putative alternative exon isoform, cryptic
and constitutive splice sites of internal (coding) exons was
performed using Alternative Splice Site Predictor (ASSP) [91]
and Regulatory RNA Motifs and Elements Finder (RegRNA
Release 1.0) [92]. SCF protein knowledge, sequence analysis,
classification were performed with the UniProtKB Protein
existence Server [93]. SCF protein secondary structure and site
interactions were analyzed using Protein data Bank (PDB) [94]
Figure 1. Schematic illustration of primer walking strategy for the ovine SCF (oSCF) mRNA/cDNA transcripts from skin. Gel pictures
show subsequent RT-PCR and RACE amplification of the resultant full-length structural coverage of s-SCF (+) and m-SCF (2). The (+)
and (2) product is indicated with two different symbols (see key to symbols). In the above figure, the arrows indicate the corresponding position of
fwd and rev primers and the split regions of 59 UTRs, CDS and 39 UTRs are labeled with respective positions and base pairs (bp). The start and stop
codon is labeled in ‘black’ (ATG) and ‘red’ (TAA) letters repectively. (A) Illustration for the full-length cDNA coverage of ovine s-SCF (+)
isofom-1.( a) Amplification of isoform specific coding region (CDS) of ovine s-SCF (+) cDNA fragment (621 bp). Individual animal of merino sheep
such as Black, Brown, White and the PCR negative control is indicated as Bl, Br, Wh1,2 (two individuals) and (2)ve, respectively; (b)3 9 RACE first round
amplification of oSCF common region (+/2) showing three different sizes of amplicon ranging from ,700 bp to 1300 bp; (b1) Isoform specific
second round (Nested 1) 39 RACE of ovine s-SCF (+) cDNA fragment (855 bp); (b2) Gel picture shows the purified 39 RACE product of 793 bp (Nested 2
amplification); (c)5 9 RACE proteolytic site specific amplification (364 bp) of ovine s-SCF (+). (B) Illustration for the full-length cDNA coverage of
ovine m-SCF (2) isoform-2. A premature termination codon (PTC) is indicated in red symbol and the resultant alternative open reading frame (ORF)
responsible for the shorter truncated product is highlighted in black open box symbol; (b3)3 9 RACE amplification (Nested-1) from (b) indicates
a 597 bp ovine m-SCF (2) amplicon and the other non-specific products (,0.7/1.2 kb); (b4) Further, Nested 2 amplification yielded a 389 bp ovine m-
SCF (2) amplicon; (b5) Gel picture shows the Nested 3 amplification of a 336 bp ovine m-SCF (2) product amplified from either (b3)o r( b 4) or (b) or
directly from the oligo(dT)18 modified primed cDNA; (d)5 9 RACE amplification of the common region (+/2) showing two oSCF cDNA products (325
and 215 bp) characterized as ovine m-SCF (2) isoform2a/ab, respectively. DNA size markers are indicated as, M1– l-DNA EcoRI/HindIII digest; and M2
- 1 kb Gene Ruler. In the above figure, the arrow marks indicate the appropriate size(s) of amplicon of the respective (RT)-PCR amplification. Note: For
simplification we removed the tag ‘scf’ from the primer notation (see. Table S2).
doi:10.1371/journal.pone.0038657.g001
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was drawn with MyDomains - Image Creator at ExPASy [96].
Ethics Statement
In agreement with the new European Directive on the
protection of animals used for scientific purposes (Directive
2010/63/EU, Article 15, Annex VIII), all animal procedures
used in the study are classified as ‘mild’ (i.e. procedures with no
significant impairment of the well-being or general condition of
the animals) and have been preemptively approved by the Animal
Ethics Committee of the University of Camerino.
Results
Identification and Isolation of the Sheep SCF cDNA
Fragment
To examine the SCF variant(s) expressed in the skin of white
merino sheep, 1–1.5 mg of total RNAs from the skin were reverse
transcribed and the synthesized single strand cDNAs were
amplified by PCR. We initially carried out the cDNA coding
(CDS) region amplification using the primer pair scffwd1 and
scfrev1 (Table S2). Primer walking and the mRNA/cDNA
structural coverage of the longer and shorter cDNA amplification
strategies from the ovine total RNA (skin) are shown in Figure 1A
and 1B. RT-PCR primers were selected based on the mammalian
nucleotide (nt) sequence alignment of the soluble-SCF (s-SCF)
cDNA encompassed to the open reading frame (ORF) of 606 bp
of the 621 bp amplicon (Figure 1A(a)) commonly known as
‘soluble or secreted form’. The purified RT-PCR amplification
product was then cloned and sequenced. Sequencing results
revealed no differences among white, black and brown clones of
the 621 bp (Figure S1A), which additionally appear to be identical
(99%) with two of the previously submitted NCBI GenBank
mRNA (partial) sequences of ovine s-SCF (U89874.1 in 2002 and
Z50743.1 in 2005; see Figure S1B) from ovarian follicles and
keratinocytes, respectively. An exception of transition at T
54Ci n
U89874.1 was observed among the 621 bp sequences. Similarly,
a transversion at C
81G was observed (see the chromatogram of
Figure S1B) in 2 out of 5 clones sequenced in white animal. The
possible allelic variant at this position will elucidate its true
identity. Nevertheless, these substitutions do not result in an amino
acid substitution change.
The virtual translation of the 606 bp CDS (of the 621 bp)
resulted in a protein corresponding to the first 202 amino acids (aa)
(Figure S1A and S1B) of the ovine SCF (oSCF), in which the last
28 aa at the C-terminus was spanned into the putative primary
proteolytic region of the long isoform i.e., s-SCF or (+) form and is
identical to three of the GenBank oSCF protein sequences of
260 aa, 202 aa and 267 aa (Acc. No. AAB49491, CAA90620.1
and P79368), respectively.
Rapid Amplification of cDNA Ends (RACE)
To obtain the full length cDNAs, we performed the 39 and 59
RACE experiments sequentially. Two different sets of primer
(Table S2) were used for RT-PCR amplification in order to
ascertain the corresponding 39 and 59 untranslated regions (UTRs)
of the two different transcript variants i.e., (+) and (2).
39 RACE – Detection of a Splice Variant of Ovine SCF
Initially, 39 RACE cDNAs were prepared as described in
materials and methods. One ml of this cDNA was used for the first
round PCR amplification with the common CDS region forward
primer and oligo(dT)18 modified as a reverse primer (Table S2).
We got an unexpected short size of approximately 350 bp
prominent amplicon since the expected 39 UTR sequence with
respect to other mammalian SCF mRNA species ranges from
,500 bp to ,4.5 kb. This was then gel purified, cloned into the
TA cloning system and sequenced. To our surprise, the BLASTN
sequence analyses revealed a 336 bp oSCF product (Figure 1B(b5)).
Overlapping the 336 bp to the 621 bp CDS amplicon, we
obtained a novel, truncated oSCF mRNA splice variant of
691 bp (without the 59 UTR). Subsequent virtual translation of the
ORF containing 546 bp resulted in a truncated oSCF protein of
181 amino acids with a unique C-terminus. The concomitant
deletion in the shorter clone resulted in the substitution of aspartic
acid (D) at aa pos. 175 with glutamic acid (G) i.e., D
175G.
Truncation would delete the C-terminal 93 aa residues of ovine s-
SCF and fully conserved till G
175 which is explained below.
Henceforth, the new truncated protein isoform has a short stretch
of 6 aa sequences right after the ‘G
175’ residue ‘KTYKHS’ as its
C-terminus (Figure S1B). This shorter form of oSCF has not been
previously reported; however, short isoforms of SCF commonly
known as membrane-bound form (m-SCF) corresponding to
245 aa lacking the proteolytic site have been reported as the (2)
form of previously reported mammalian species including human
[97,100], mouse [11], cow [98] and avain [99]. The newly
identified 181 aa oSCF (2) form differed from the 245 aa by the
deletion of 64 aa at the C-terminus corresponding to the
transmembrane and intracellular region. Hence, this novel cDNA
variant could be recognized as the ‘membrane-anchored’ SCF
protein (m-SCF) form and named as ‘SCF truncated isoform-2’,
designated hereafter as (2) form since it lacks the primary
proteolytic site. To our knowledge, this information of oSCF
truncated (2) protein product is previously unreported in other
mammal species especially in skin.
The remaining short 145 bp (after removing the adapter
sequences from the oligo(dT)18 modified primer) including the
polyA nucleotides belong to the 39 UTR of ovine m-SCF (2) form.
Mammalian genome scanning for the SCF gene represented that
this novel 39 UTR of ovine m-SCF (2) form corresponds to the
intervening sequence in between exon 5 and exon 6 i.e., intron-5
of the (+) form. Here we hypothesis that the premature truncation
could be the result of alternative use of the splice donor/acceptor
site in the intervening sequences. Later, this short 39 UTR
amplification was confirmed (Figure 1B(b5)) in black and brown
animals by direct sequencing but did not considered for further
characterization such as SNPs.
In order to identify the 39 UTR of the (+) form, we used the
same 39 RACE cDNA preparation as mentioned above. One ml
was used for the first round amplification with the common CDS
region forward primer and oligo(dT)18 modified as the reverse
primer (Table S2). We obtained three different RT-PCR
amplicons ranging from ,700 to 1300 bp (Figure 1A(b)). At this
stage it was difficult to substantiate this amplification. Hence, we
performed three individual nested amplification sequentially using
oligo(dT)18 modified as the reverse primer with the Nested forward
primers (Table S2) for the consequent PCR reactions. All these
amplified nested fragments were gel purified, cloned into the TA
cloning system. Colonies were screened by colony PCR as well by
restriction digestion, and the positive clones were subjected to
sequencing.
Sequencing results showed three different sizes of fragment, one
each from the Nested amplification (Table S2) viz. 597 bp
(Figure 1B(b3)); 389 bp (Figure 1B(b4)); and 336 bp
(Figure 1B(b5)) as positives for oSCF. Sequence analysis by
BLASTN, BLASTP and ClustalW2 revealed all three products as
ovine m-SCF (2) form and are identical to the one described
above i.e., 336 bp for the reason that the (2) form override (+)
Alternative Splicing of the Sheep SCF Gene
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38657form during the RT-PCR amplification. In other words, there
exists a considerable difference in the mRNA expression level
between these two transcript variants which is further explained in
the later section. The rest of the amplicons were found to be non-
specific including the two expected amplicons viz. ,0.7/1.2 kb
(Figure 1B(b3)) amplified from the primary RT-PCR amplification
(Figure 1A(b) and B(b)).
In all the above cases, we obtained always the (2) form, hence
we designed a splice variant specific Nested forward primer (Table
S2) with higher Tm for the (+) form. The primer was designed in
between two exonic junctions (see Figure 1A and 2(c)) spanning
into the proteolytic site viz. exon 5 into exon 6 in reference to the
human, mouse, dog, horse SCF (source: Ensembl). The second
round 39 RACE amplification (Nested 1; see Table S2) was
performed with 1 ml of the primary reaction product using (+)
form specific forward primer (Table S2) and oligo(dT)18 modified
reverse primer into a final PCR volume of 50 ml. The RT-PCR
yielded an amplicon size of 855 bp (Figure 1A(b1)). Further third
round amplification (Nested 2; see Table S2) yielded the expected
793 bp amplicon with some non-specific amplicons. The purified
fragment of 793 bp (Figure 1A(b2)) was then cloned and
sequenced. Sequence analyses by BLASTN and BLASTP
confirmed the oSCF and named as ‘SCF isoform-1’, hereafter
referred as (+) form, which is the counterpart of previously
reported ‘soluble’ SCF (s-SCF) sequences in other vertebrate
species [99–103] (source: GenBank, NCBI). Overlapping and
editing of the 793 bp 39 UTR fragment with the 621 bp CDS
fragment, we obtained a total length of 1330 bp (without the 59
UTR). The ORF of 825 bp corresponding to the deduced amino
acid sequence of 274 aa revealed it as the s-SCF (+) form,
indicating that this cDNA encodes the ‘soluble’ form of oSCF.
This ovine s-SCF (+) form included the stretch of 28 aa recognized
as a putative primary proteolytic site (Figure S1B) right after the
D
175 at its C-terminus as observed in the previously reported
sequences [99–103]. The remaining long 505 bp (after removing
the adapter sequences from the oligo(dT)18 modified primer)
including the polyA nucleotides belong to the 39 UTR of ovine s-
SCF (+) form. The other two amplicons (data not shown) were
found to be non-specific and omitted from further characteriza-
tion.
59 RACE
To determine the 59 UTR of the oSCF (+) form, a gene specific
59 RACE cDNA was synthesized using the proteolytic site specific
reverse primer (Figure 1A; see Table S2) as described in materials
and methods. Three ml of the dC-tailed cDNA was subjected to
the first round RT-PCR amplification with the respective forward
and reverse primer (Table S2). After the primary RT-PCR, the
expected size of ,780 bp amplicon was not detected on the gel.
Consequently, a second round nested amplification was performed
with a common CDS reverse primer and the forward adapter
primer (Table S2) using 2–3 ml of the primary enriched RT-PCR
reaction. Upon electrophoresis (1.5%), the secondary reaction
yielded a single clear amplicon of ,380 bp as expected. BLASTN
results confirmed the sequenced clone of 364 bp (Figure 1A(c))
with the other mammalian s-SCF (+) form and was characterized
as ovine s-SCF isoform-1 i.e., (+) form. Overlapping and sequence
comparison of this 59 UTR clone to the 1330 bp (CDS +39
RACE), resulted in a deduced 189 bp 59 UTR sequence of ovine
s-SCF (+).
The 59 RACE RT-PCR for the oSCF (2) form was performed
in a final PCR reaction volume of 50 ml containing 3 ml of the dC-
tailed cDNA which was synthesised by a common CDS reverse
primer (Figure 1B; see Table S2) along with all other necessary
components as described in materials and methods. The first
round enrichment PCR amplification was carried out using the
same CDS reverse primer and the forward adapter primer (Table
S2). The second round nested amplification was performed with
another common CDS reverse primer and the forward adapter
primer (Table S2) using 2–3 ml of the primary enriched RT-PCR
reaction. Upon 1.5% gel electrophoresis, the secondary reaction
yielded two distinct amplicons in the range of 200 to 330 bp. The
two amplified 59 RACE products were gel purified, cloned and
sequenced. Sequence analysis revealed the two oSCF 59 RACE
products of sizes 325 bp and 215 bp (Figure 1B(d)). These two 59
UTR products were not detected in the (+) form specific 59 RACE
cDNA (Figure 1A(c)) though the primer combination rely on the
common CDS region. Hence, these two 59 UTR products were
characterized and named as ‘SCF isoform-2a (2) and 2b (2)’,
respectively (Figure S4(a1)). In order to confirm the amplification,
this common 59 RACE was repeated twice along with the (+) form
specific 59 RACE RT-PCR. Overlapping and sequence compar-
ison of these two clones with the 691 bp (CDS +39 RACE)
revealed a deduced 144 bp, a 34 bp 59 UTR sequences (after
subtraction of the forward adapter primer sequence) for the two
respective clones (325 bp, 215 bp).
Genomic DNA – Spliceosomal Intron-5 Specific
Amplification of oSCF
To verify the alternative splicing (AS) event that resulted in the
shorter mRNA transcript i.e., ovine m-SCF (2) form, we
amplified the intervening sequence between two exons. The
sequenced chromatogram from the cDNA and gDNA of oSCF
illustrating a PTC followed by the p(A)11/18 tail signal is shown
in Figure 2(a,b), respectively. The reference SCF genomic locus
at the exon 5-intron(5)-exon 6 splice junction was determined in
comparison to the orthologous SCF gene assembly of human,
mouse, rat, cow, horse and dog (source: Ensembl). The genomic
DNA (gDNA) was obtained from the blood of white merino
sheep. A expected amplicon size of 948 bp amplicon (Figure 2(d))
was amplified using an exon-5 (common CDS) specific forward
primer and exon 6 specific reverse primer (+ form, proteolytic
site; Table S2) as shown in Figure 2(c). Sequence analyses and
orthologous comparison of the oSCF gene product (948 bp) with
other mammals revealed that the first 136 bp corresponds to
exon 5, followed by an intron-5 of 729 bp (Figure S4(b)) and an
exon 6 containing 83 bp which encodes for the primary
proteolytic site. This result was compared with the shorter
cDNA transcript. The first 161 nt including a 11 bp polyA (pA)
stretch of the intron-5 exhibited 100% identity to the nt pos.
668–835 of the shorter cDNA (Figure S4(c)). However, careful
annotation of the 161 nt unveil a premature stop codon at nt
pos. 21–23 of the 729 bp intronic sequnce. Figure 3 shows the
oSCF gene structure(s) in reference to mouse, dog and human
SCF gene (see also Figure S2 for the humanSCF alternative
forms). The overall similarity for this 948 bp DNA splice region
in other vertebrates was found to be highest with goat and cow
SCF (99 and 94%) where as the lowest was detected with chicken
and zebra finch SCF (62%).
Intron-5 has a constitutive 59 splice donor (GT) at its start and
six other alternative isoform/cryptic splice donor (GT) sites (Figure
S4(b)). Similarly, it has a constitutive 39 splice acceptor (AG) site
exactly at the end of the intron-5 and five other alternative
isoform/cryptic splice acceptor (AG) sites (Figure S4(b); see also
Figure 3(d)) as predicted by ASSP, RegRNA [91,92]. Seven
important sequences, the so called the ‘branch site’ (BS; Figure
S4(b)) viz. CU(Pu)A(Py) are located 20 to 75 bases upstream of the
predicted acceptor site. Of which ‘CUGAC’, ‘CUAAU’ and
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38657Figure 2. Sequencing chromatogram of cDNA in comparison with the gDNA amplification of oSCF gene. (a) Complementary DNA
(cDNA) chromatogram shows the CDS, GT repeats and p(A)18 tail adapter primer as ‘black dotted oval mark’ and a premature termination codon
(PTC) as ‘red dotted oval mark’ on the 39 RACE product (336 bp, see Figure 1B(b5)); (b) Genomic DNA (gDNA) chromatogram shows the counter part
of the above cDNA illustration (a) on exon 5 to exon 6 intervened by intron-5 sequences of the oSCF gene; (c) Amplification scheme of 948 bp splice
junction covering exon(5)-intron-5-exon(6) of the oSCF gene with reference to human and mouse. The two exons 5, 6 are differentiated by ‘open and
shaded box’ respectively. Arrows over the boxes indicate the fwd and rev primer. Different symbols on the intron-5 indicate the part of retained
intronic sequences (161 bp) by a PTC along with the stretch of p(A)11 signal (see key to symbols below the diagram); (d) Gel picture shows the PCR
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sites that could be involved in the AS event. PolyADQ [88]
prediction revealed two polyadenylation signal (PAS) of the type
‘AAUAAA’ in the 729 bp gDNA (intron-5; Figure S4(b)), but
present after p(A)11 stretch hence was not considered to be part of
the polyadenylation. However, here we hypothesis that the two
other single base variants of ‘AAUAAA’ [104] such as type
‘UAUAAA’ at nt pos. 24 (right after the stop ‘TAA’), 126 and
‘AAUAUA’ at nt pos. 83, 124 found just before p(A)11 bp stretch
could be responsible for the polyadenylation process of the shorter
mRNA (2) transcript (Figure S4(b); see also Figure 3(d)). These
two strong polyA signals are also present in the cDNAs of the
respective oSCF mRNA transcripts (Figure S4(c)). The other two
single base variants ‘AAUAGA’ and ‘UAUAAA’ detected at
407 nt and 427 nt (Figure S4(b)) away from (pA)11 stretch,
respectively, in the same intron, are not considered further the
AS analyses.
Chromosome Location and Genomic Structure of the
oSCF (KITLG)
Upon scanning through the sheep genome Oarv2.0 (March
2011 – till date) covering position from 124,495,129 to
124,515,933 of Ovine (Texel) Version 2.0 (current) Genome
Assembly we obtained the mere size of OAR3: 20.8 kbp (data not
shown). It represents only 19% of the known SCF gene size when
compared to human (108.74 kbp), mouse (104.78 kbp), cow
(122.28 kbp) and dog (100.21 kbp) (source: Ensembl). The gene
encoding the ovine SCF (NCBI gene ID: 443371) is located within
a syntenic group on chromosome 3 [105], corresponding to the Sl
or kitlg gene locus. This portion of ovine chr 3 is homologous to
cattle chr 5. Hence, a comparative chromosomal mapping
(Figure 4) was performed at the NCBI Map Viewer [84] of the
sheep SCF to the cow SCF i.e., O.ari c h r5t oB.tau chr 5 and O.ari
c h r3t oB.tau chr 5. Genomic DNA and cDNA sequence
comparison and prediction [63] revealed that the oSCF gene
consists of 9 exons interrupted by 8 introns to the dog (Figure 3(e)),
pig, horse SCF gene where as in comparison to human,
chimpanzee, marmoset, mouse (Figure 3(e)) and rat including
the unfinished alpaca genome (source: Ensembl), oSCF gene has
been characterized by 10 exons and 9 introns. Comparative
analyses of oSCF (+) protein to the dog and mouse SCF gene
assembly exhibited 96/90.1 and 93/80.6 match ratio and %
identity, respectively. Similarly, oSCF (2) protein showed the
match ratio and % identity of 91/87.2 and 90/77.7 to dog and
mouse SCF gene assembly, respectively. Among the 9/10 exons, it
is predicted by gene annotation (source: Ensembl) that the exon 5
and exon 6 has its importance in determining the final protein
product through AS event(s) and the longer exon 10 (9)
corresponds to ,4.4 kb 39 UTR in human, chimpanzee, mouse,
rat and goat in contrast to the shorter 39 UTR in sheep (reported
in this study), cow, pig, horse, dog, cat and panda (source:
Ensembl).
Protein Characterization of the Ovine SCF s-SCF (+) and
m-SCF (2)
The molecular mass of the oSCF isofoms presented in this study
as predicted by EditSeq, DNASTAR [62] is 31.1 kDa and its
theoretical iso-electric point is 5.236 for the s-SCF (+) isoform
corresponding to the 274 aa. Similarly, the m-SCF (2) isoform has
a molecular weight of 20.6 kDa with a theoretical iso-electric point
of 6.002 for the 181 aa residues.
Topological features of both the isoforms (+ and 2) of ovine
SCF in comparison to the human SCF is given in Figure 5(a,b). In
ovine s-SCF (+) form, the first 25 amino acids contain features
(Figure 5a) of a signal peptide, followed by an extracellular mature
chain (aa pos. 26–215), a putative hydrophobic transmembrane
region (aa pos. 216–238), and a 35 amino acid intracellular
domain (aa pos. 239–274). The 28 aa proteolytic site resides at aa
pos. 175–202 which includes a N-linked glycosylation site at aa
pos. 196. The four cysteine residues found within the extracellular
domain that may result in disulfide bridges viz. (29-s-s-114), (68-s-
s-164) and the three other N-glycosylation sites found in the
extracellular domain at aa pos. 90, 97, 145 are conserved with all
the mammalian s-SCF (Figure S3(d)). The above described
features of ovine m-SCF (2) form has been shown in Figure 5(b),
which depicts the shortage/deletion of the primary proteolytic site
including an N-glycosylation site, a trasmembrane domain
(necessary to make a soluble product) and a cytoplasmic domain.
The sketch of oSCF gene transcription and translation is shown in
Figure 5(c).
Conservation of the Ovine s-SCF Protein Isoforms
Using the default settings of NCBI, BLASTN and BLASTP
search was conducted with ovine s-SCF (+) form of 825 bp CDS
and its deduced 274 aa as query sequences, respectively. Multiple
sequence alignments (MSA) [64] (Figure S3(a,b,d)) of the
nucleotide and the deduced amino acid sequences belonging to
different mammalian representatives indicated that the sheep SCF
was highly conserved and found to have between 57% and 99%
nucleotide similarity and 19% to 99% protein identity
(Figure 6(a,d)). The highest identity was with the goat SCF where
as the lowest was with gold fish and zebra fish SCF for nucleotide
and protein respectively viz. goat (99/99%), cow (97/98%), pig
(95/94%), cat (94/90%), panda (93/90%), horse (93/89%), dog
(92/88%), human and chimpanzee (91/86%), rabbit (90/84%),
marmoset (90/83%), rat (88/82%), mouse (87/80%), zebra finch
(74/55%), chicken (73/53%), zebra fish(59/19%) and gold fish
(57/26%). The graphical logo representing the conservation of
oSCF splice junction (intron-5) with GT repeats, poly(A)11 stretch
and the constitutive splice donor (GT) and acceptor (AG) sites are
shown in Figure 6(b).
Similarly, the deduced 181 aa sequence from 546 bp CDS of
the ovine m-SCF (2) form shares 49–99% identity with the
predicted m-SCF (2) form of the same length of a number of other
vertebrate species (Figure 6(a,c); see also Figure S3(a,c)) including
avian SCF. The highest identity was with the goat (99%) followed
by cow (95%) where as the lowest was noticed with chicken (49%)
followed by zebra finch SCF (51%).
Skin Expression of the Two Ovine SCF Splice Variants
Initially, to verify any eventual difference(s) between the
expression level of two different splice variants of oSCF (+/2)
four sets of primer (summarized in Table S2) were used as
described in materials and methods. Three individuals of white,
black and brown animals were subjected to a single round RT-
PCR amplification. The RT-PCR reactions gave fragments (see
Table S2 for details) exhibiting almost the same level of band
intensity for both the (+) and (2) form (data not shown). In
contrast, Northern blot analysis showed substantial differences in
amplification of 948 bp fragment corresponding to the above schema (c) of oSCF gene from blood gDNA; In the picture, arrow mark indicates the
exact size of amplicon; M1 indicates DNA size marker of l-DNA EcoRI/HindIII digest; and (2)ve represents PCR negative control.
doi:10.1371/journal.pone.0038657.g002
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juncture, we propose that the oSCF gene expression in white,
black and brown animals at mRNA transcript level is mediated via
an intron-5 AS event (Figure 3(c,d). However, both forms (+/2)
are biologically active and reported to have different effects on
cells [9–11,20]. The regulation of processing of the proposed
secondary proteolytic cleavage site encoded by exon 7, could play
a critical role in the function of membrane-associated SCF (2)
protein [10].
SCF UTR Regulatory Motifs that Affect mRNA Stability
The different 59 and 39 UTR sequences of sheep SCF(s) were
searched against the UTRdbases [86,92] for the post-transcrip-
tional associated regulatory elements located in the 59 and 39
Figure 3. Gene architecture of ovine SCF gene in reference to human, mouse and dog.( a) Schematic representation of human SCF
(huSCF) gene is shown. It consists of 10 exons (open boxes) intervened by 9 introns (linear black lines). Regular splicing and polyadenylation
generates the full length huSCF mRNA transcript variant-b, a longer (+) form (5460 bp) encoding for a soluble product (273 aa; see Figure 5a); (b) The
84 bp exon 6 encoding for the 28 aa proteolytic site is skipped by an AS event of the huSCF gene is shown. The resultant full length huSCF mRNA
transcript variant-a, known as (2) form (5376 bp) encodes for a membrane-bound product (245 aa; see Figure 5b); (c) Schematic representation of
ovine SCF (oSCF) gene is shown. Regular splicing of exons 1–9/10(?) generate the full length oSCF (+) mRNA transcript (1519 bp) that encodes for
a soluble product (274 aa; see Figure 5a); (d) Conversely, the possible AS events on intron-5 (Ref. human, mouse and dog) resulted in an alternative
ORF with a premature termination (red symbol, PTC; see key to symbols). This resulted in retaining of 161 bp intronic sequence and completely
eliminating (skipping of) the involvement of exon 6–9/10(?). The deduced protein sequence of this novel, shorter splice transcript variant (835 bp)
resulted in 181 aa (see Figure 5b), a membrane-bound product of oSCF (2). In the above illustration, the open square or rectangle box symbolize
exon and inverted triangle box symbolize intron. The open and shaded ‘black sparkle’ symbol on exon 10 (in 3a,b), exon ‘?’ (in 3c) and intron-5 (in 3d)
all indicate the posssible position of predicted polyadenylation signal (PAS) sites. The two different sizes of the opened ‘black sparkle’ symbol (in 3a,b)
denote the frequency of the common PAS such as ‘AAUAAA’ (8–12 times) and ‘AUUAAA’ (4–6 times) in the longer 39 UTR of human, goat, mouse and
rat. In contrast, the shaded ‘black sparkle’ symbol (in 3c,d) represents the other single basse ‘variants’ of PAS (see text in Results). Exon ‘?’ symbol (in
3c) represents the uncertainity of exon 10 position for oSCF (+). A ‘black hook’ symbolize the capped 59 end and p(A) represents the polyA stretch on
the preRNA, mRNA, respectively. The point of transcription termination (TAA) is symbolized as ‘red’ mark on intron-5 of oSCF (2) followed by the
illustration of two possible mechanisms that resulted in a PTC of oSCF (2) (in dotted lines). The ASSP predicted constitutive and/or alternative splice
donor (GT) and splice acceptor (AG) site(s) are labeled in blue and red letters respectively; (e) Schematic representation of the soluble oSCF (+) gene
structure is shown. The exons/introns and the location of non-coding regions are determined in comparison to the mouse (chr 10) and dog (chr 15)
SCF gene. The ‘intron (?)’ labeled in blue on the oSCF (+) in reference to mouse chr 10 indicates that the corresponding intron-7 is incomplete at that
point i.e., it doesn’t show appropriate 59 and/or 39 splice sites; (f) Figure shows the gene stucture of membrane-bound oSCF (2). The ‘black line’ at
the end of exon 5 of oSCF (2) in reference to mouse and dog indicate ‘gap’ i.e., coding sequence not found on the respective contig. The ‘vertical red
lines’ over the exons indicate ‘mismatch’ of the oSCF (+) and (2) protein with dog (27 aa and 22 aa) and mouse (53 aa and 39 aa) SCF gene.
doi:10.1371/journal.pone.0038657.g003
Alternative Splicing of the Sheep SCF Gene
PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e38657untranslated regions. Among the cis-elements that play a role in
translation down-regulation are an upstream open reading frames
(uORFs) [106] at nt pos. 80, 193 for the (+) form and at nt pos. 35,
148 for the (2) form; and a polypyrimidine motif, known as
terminal oligopyrimidine tract (TOP) [107] at nt pos. 1, 5 located
in the 59 UTR of oSCF (+) form are shown in Figure S4(a1). The
critical regulatory sequences, known as Cytoplasmic Polyadenyla-
tion Elements (CPEs), are AU-rich elements (AREs) [108] located
in the 39 UTR near by the canonical nuclear polyadenylation
element (AAUAAA), key sequence features controlling mRNA
deadenylation and decay. Surprisingly, sheep SCF mRNA has the
following single base variant [104] of the type CAUAAA (nt.
1076), AAUGAA (nt. 1080), UUUAAA (nt. 1091), UAUAAA (nt.
1225), AAUAGA (nt. 1441), and AACAAA (nt. 1095, 1183, 1486)
for the (+) form (Figure S4(d)) and UAUAAA (nt. 691, 792),
AAUAUA (nt. 750, 791) and AGCAAA (nt. 799) for the (2) form
(Figure S4(c); see also Figure S4(b)) as its PAS, which are required
for proper poly(A) addition. The other regulatory 39 UTRs found
in the oSCF (+) form are Bearded (BRD) Box [109], ‘AGCTTTA’
at nt pos. 1088, 1391 and Musashi binding element (MBE) [110],
‘ATAGT’ at nt. pos. 1422, 1458 (Figure S4(d)).
mRNA Structural Characterization
In addition to the coding region (+/284 bp proteolytic site),
SCF mRNA(s) has four notable features relevant to its secondary
structure (Figure 8(a,b)). First, the 59 UTR is enriched in G+C
nucleotides (Figure S4(a3)), with 64% and 60% or 56% (G+C
content) in the 189 nt and 144 nt segment for the (+) and (2)
form respectively. Second, the 59 UTR segment has specific
trinucleotide elements (Py-G-C; Figure S4(a1)), in our case ‘CGC’
at nt pos. 4, 16/18, 33, 36, 68, 100, 154, 176 and and ‘TGC’ at
nt pos. 66, 81, 94, 103, 109, 116, 146, 157, 179 that are known
to cause DNA polymerase pausing [111]. These trinucleotides
(CGC, TGC) which accounts for 9.6% of the ovine s-SCF (+)5 9
UTR segment (189 bp), could attribute to the smaller 59 RACE
cDNA product(s) for example, the one of oSCF isoform-2a (2)
(Acc. No. GU386374; Figure S4(a1)). Third, sheep SCF mRNA
contains a frequent hexamer direct repeats (DRs) i.e.,
‘CGCTGC’ (1.6%) at nt pos. 100, 154, 176 located in the 59
UTR of (+) form (also present in (2) form but nt pos. differs; see
Figure S4(a1)). This repeat is highly conserved among mamma-
lian SCF mRNAs (Figure S4(a2)). Fourth, the 39 UTR has a DRs
containing a consecutive hepatamer ‘GTGGGGG’ at nt pos.
1461, 1468 in the (+) form which is highly conserved only in goat
(Figure S4(d)). In contrast, a perfect dinucleotide repeats (GT)5 at
nt pos. 775 is present in between the hepatamer tandem repeats
‘CAAATAT’ at nt pos. 748, 801 in the (2) form, are also highly
conserved with goat but varies only in the dinucleotide repeats
with ‘AT’ for cow, dog and horse as shown in Figure S4(c). In
between this feature, there exists a putative alternative isoform/
cryptic splice donor (GT) at nt pos. 117 of 729 bp intron-5 of
oSCF (Figure S4(b)) with 92.5% score as predicted by the ASSP
[91] classification.
MicroRNA Targets: Another Type of cis-acting Regulatory
Element
The above described differences between the two ovine splice
variants i.e., (+) and (2) in the conservation of non-coding
sequences (Figure S4(d)) suggests that the 39 UTRs, might have
a functional role in gene regulation.
A number of potential miRNA target sites are found within the
longer ,4.4 kb 39 UTR sequence of human SCF (data not
shown). However, in sheep, the analyzed miRNA sites that are
located in the 505 bp 39 UTR of the ovine s-SCF (+) form belongs
Figure 4. NCBI Map Viewer of ovine SCF (oSCF) aligned to the bovine SCF gene. The comparative map depicts unknown map region (in red
dots) of the oSCF gene to the counter-part of bovine SCF (KITLG) on chr_5:Btau_5.2 displaying regions of 20,582,700–20,618,400 bp. Arrows indicate
mapped GenBank records (Acc. No.) with description, respectively.
doi:10.1371/journal.pone.0038657.g004
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370, and two sites for miR-132/212, miR-320/320abcd
(Figure 9(a)) where as miR-669f/a/o-3p, miR-466b and miR828b
are detected on the shorter 39 UTR segment (144 bp) of ovine m-
SCF (2) form (Figure 9(b)). Interestingly, the 8-mer miRNA (miR-
669f) has a high context score (87 percentile) which binds to the
Figure 5. Schematic representation of the topological characteristics of two different ovine SCF (oSCF) protein products in
comparison to human SCF (huSCF).( a) Illustrates the identical topological features for the soluble oSCF (+) and huSCF (+) which corresponds to
the 273 aa vs. 274 aa, respectively. The D
174/175G represents the change of aa residue for the alternative natural variant i.e., right at the proteolytic site
(28 aa, ‘green line’). The difference in the position is due to sequence divergence of soluble oSCF (+) which has an additional ‘Glu’ residue at ‘E
154’ (see
Figure S3d). (b) Demonstrates the difference in topological features of the membrane-bound oSCF (2) and huSCF (2) which corresponds to the
181 aa vs. 245 aa, respectively. This novel ovine m-SCF (2) has a unique C-terminus with an additional uncharacterized 6 aa residue (176–181, see key
to symbols) right after D
175G. Given below the diagram (in 5a, b) are the appropriate topological features (see key to symbols) of human and ovine
soluble SCF (+) and membrane-bound SCF (2) with referencce to UniProt ID. P79368 and P21583; (c) Schematic representation of ovine SCF gene
transcription and translation in skin (hypothetical view). The corresponding oSCF protein products, s-SCF (+) and m-SCF (2) and their topological
characteristics are labeled and highlighted respectively.
doi:10.1371/journal.pone.0038657.g005
Figure 6. Graphical representation of evolutionary conservation of sheep SCF isoforms.( a) Percent of conservation was calculated for
sheep, goat, cow, pig, cat, dog, panda, horse, human, chimpanzee, marmoset, mouse, rat, rabbit, chicken, zebra finch and fishes, such as zebra fish,
gold fish using the multiple sequence alignment (MSA) tool, ClustalW2 with four different datasets (provided on request). The Circos graphical table
view represents the sheep soluble, s-SCF (+) and membrane-bound SCF, m-SCF (2) nucleotide (nt) and protein (aa) as the query sequences (in black
dotted left bracket) against 17 other vertebrate species. Four different colour small bars on the query sequences represnts the four different data sets
of sheep s-SCF (+) and m-SCF (2) nt/aa sequences. The 15 different colour ribbons passing through each other represent respective vertebrate
species and the percent identity is indicated outside as the boundary. The four different colour small bars over the 15 vertebrate species as against 15
different colour small bars above the sheep query sequences represnts the percent identity among each other. The scale over each species (above
small bar) represents the total score obtained from the sequence coverage; (b) Graphical logo representing the conservation of oSCF splice junction
(intron-5) which was generated by MUSCLE alignment (manually predicted for other species), depicting the GT repeats (black oval dotted lines)
proximal to the poly(A)11 stretch (black dotted right brace symbol). The constitutive splice donor (GT) and acceptor (AG) sites are circled by black
dotted lines along with one of the proposed usage of alternative/cryptic splice donor site (GT) (see Figure 3f). Numbers below the logo indicate the
nucleotide/amino acid position of the MUSCLE aligned sequences; (c) Logo representing the 23 nt conservation of the m-SCF (2) form (novel
sequence reported in this study) and its deduced 7 aa new C-terminus is shown; (d) Graphical logo representing the 84 nt conservation of the s-SCF
(+) form and its deduced 28 aa proteolytic site is shown. Numbers below the graphical representation of (c), (d) indicate the actual nucleotide/amino
acid position. The height of the letters on each logo represents the relative frequency of each nucleotide/amino acid in a given position.
doi:10.1371/journal.pone.0038657.g006
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(Figure 9(b)).
Homology Modeling
The predicted three-dimensional structures of the deduced SCF
protein corresponding to 141 aa and 132 aa residues were
modelled using the best matched PDB templates with 90–100%
identity to the individual chains such as 1EXZ, 2E9W:chainC,D
and 1SCF. The structure was predicted as using Modeller 9v2 [54]
as described in materials and methods. The quality assessment of
the modelled structures were performed at SWISSMODEL
Workspace [52].
Topologically, the modelled oSCF structure has a core of four
alpha(a)-helices (aA, aB, aC and aD) and two antiparallel beta(b)-
strands arranged to form a protomer i.e., b1 between aA and aB
and b2 between aC and aD. Apart from this, it consist of three
other additional unique conformations i.e., one-turn helix, aB’
between b1 and aB, an hairpin loop between aB and aC at the
dimer interface, and an extra one-turn helix, aD’, in the C-
terminal extension [112]. This conformation is in accordance with
the crystal structure determined for 1EXZ, 1SCF and 2E9W
[112–114]. The best models were choosen based on the quality
assessment reports of ProCheck [115] and Promotif [116]. The
calculated Ramachandran plot showed 91–95% of the aa residues
lie in the core region for those structures modelled using Modeller
9v2, representing the most favourable combinations of phi-psi
values, guiding to the better stereochemical quality of the oSCF
protomers while for the one modelled using an automated
comparative protein modeling server at SWISS-MODEL, ex-
hibited 70.7% in the core region. Six out of eighteen modelled
strcutres were picked and the superimposition of one of the oSCF
monomer model to the PDB template 1EXZ:chainB is shown in
Figure S5. All these observations suggest correct structure and
folding for the modelled putative oSCF.
Molecular Phylogenetic Analyses
The evolutionary divergence of sheep SCF cDNAs and its
corresponding protein sequences were studied using other
vertebrate sequences from the GenBank, Ensembl and necessary
BLAT searches. Except the s-SCF (+) form, the spliceosomal
intron junction on the DNA sequences and the m-SCF (2) form
Figure 7. Expression of ovine SCF in skin. Northern blot analysis
show ovine SCF (+) and (2) mRNA expression. Ovine 18S rRNA was used
as an internal control. Northern blot analysis was carried out with a DIG-
labeled cDNA probe for SCF and 18S rRNA (see Table S2) as described in
Materials and Methods section. Br, Bl, Wh represents individual of
Brown, Black and White merino sheep, respectively.
doi:10.1371/journal.pone.0038657.g007
Figure 8. Ovine SCF RNA fold model explaining the observed results.( a) Secondary structure predicted for the major 1519 nt s-SCF (+)
mRNA. The m-fold circle diagram, generated by minimal free energy (dG=2437.3 kcal/mol) indicate G–C, A–U and G–U base pairs in red, blue and
green arc lines, respectively. It also differentiates the 825 nt coding and 505 nt non-coding region fold by the vertical black dotted line which divides
the circle diagram. The 189 nt GC-rich segment of 59 UTR which forms a dense secondary structure and the presumptive splice site of 84 nt
proteolytic segment are highlighted and labelled in cyan and dark red dotted line respectively. The start (ATG) and stop (UAA) codons are labeled in
bold blue and red letters respectively. The numbers present outside the circle diagram indicates the nucleotide position in base pairs (bp) at every
100 bp intervals; (b) Stemloop secondary structure representation of 1519 nt s-SCF isoform-1 (+), 825 nt m-SCF isoform-2a (2) and the partial image
depicting the 59 UTR segment fold of 725 nt m-SCF isoform-2b (2). The major structural features in illustration (a) and (b) are labeled alike. Except the
GC-rich 59 UTR segments where in I (189 nt), II (144 nt) and III (34 nt) represent the difference in 59 UTR fold (light blue/cyan dotted arrows pointing
to the corresponding dotted oval shape; see also Figure S4(a1,2,3). Similarly, IV (+84 nt) and V (284 nt) represents potential fold difference for the
proteolytic segments (dotted dark red arrows directd to the corresponding expanded structures).
doi:10.1371/journal.pone.0038657.g008
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sequences.
Five different alignments were constructed for the phylogenetic
analysis (data sets provided on request): 1) SCF (+) CDS nucleotide
data sets (14 mammals, 2 avian and 2 fish, 822 nt unambiguously
aligned characters); and 2) SCF (+) CDS deduced protein
sequences (13 mammals, 2 avian and 2 fish, 274 aa unambigu-
ously aligned characters); 3) Predicted SCF (2) CDS nucleotide
data sets (12 mammals and 2 avian, 543 nt unambiguously aligned
characters) and 4) predicted SCF (2) CDS deduced protein
sequences (11 mammals and 2 avian, 181 aa unambiguously
aligned characters); (5) Predicted SCF DNA sequences concate-
nated to the exon 5-Intron(5)-exon 6 (12 mammals and 2 avian,
948 nt unambiguously aligned characters). Unambiguously MUS-
CLE [47] aligned sequences were confirmed by eye, and
unnecessary gaps were excluded from the alignments with
GBLOCK program [65] prior to phylogenetic analyses. Phyloge-
netic relationships were inferred from all five alignments using
neighbour-joining (NJ), maximum likelihood (ML) and Bayesian
inference (BI) methods as described in materials and methods. The
best fit models were scrutinized from 88 nt models [81] and 56 aa
models [82] based on the AIC/AICc/BIC/2lnL scores. After the
appropriate model selection, the final trees were constructed using
the simple p-distance for NJ method, JTT+G, a protein model for
ML, BI methods and GTR+G and/or HKY+G for ML, BI as the
nucleotide substitutions models. Numbers on the respective nodes
denote the supportive bootstrap values of NJ, ML in percentages,
and Bayesian posterior probabilities, respectively with the separa-
Figure 9. Location of potential miRNA target sites on the 39 UTR sequences of oSCF (+/2). Vertical black bars on the schematic diagram
represent miRNA target sites on the 39 UTR region. Open and dotted boxes represent potential miRNA target sites and sequence conservation,
through evolution in sheep, goat, cow, dog, horse and pig. (a) The predicted potential binding site of miR-27a,b on the 39 UTR of ovine s-SCF (+) and
stemloop structure (mfold) of the miR-27a,b is shown. The seed sequences (nt. 2 to nt. 8) of the miR-27a,b is shown in red, bold letters. The target
nucleotides involved in pairing are shown in blue, bold on the ovine s-SCF (+). The nucleotides involved in pairing outside the seed sequence are
underlined in black; (b) The predicted potential binding site of miR-669f-3p on the 39 UTR of ovine m-SCF (2) and stemloop structure (mfold) of the
mature miR-669f-3p is shown. The miR-669f-3p target sequence is located on the non-coding intron-5 closest to exon 5. The mature miR-669f-3p is
shown in red, bold letters. The target nucleotides involved in pairing are shown in blue, bold on the ovine m-SCF (2).
doi:10.1371/journal.pone.0038657.g009
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GTR+G, HKY+G models, the other useful nucleotide substitution
models for our evaluated data sets include TIM3+G, TPM3uf+G,
TVM+G, TrN+G and TPM1uf+I+G. All these evaluated models
differ in their respective scores by 65 and produced consistent tree
topologies.
All five constructed phylogenetic tree (Figure S6(a-e)), based on
oSCF nucleotide and protein sequences (5 different data sets,
provided on request) produced similar monophyletic clusters as
mammals, avian, and fishes indicating that all the species
delineated successfully and was found to be in harmony with the
established positioning of these vertebrates. In the tree (Figure
S6(c,d,e)) pig-1, pig-2 represents two possible predicted m-SCF
amino acid, nucleotide and DNA splice junction sequences,
respectively (data sets provided upon request). Note: The s-SCF
and m-SCF protein sequence of chimpanzee has 100% identity,
hence omitted from the MLA and further tree analyses.
Discussion
Stem cell factor (SCF), characterized as mast cell growth factor
(MGF), is a multifunctional growth factor for haematopoietic
progenitors, germ cells, melanocytes and mast cells [117]. It is
mainly produced by fibroblasts, keratinocytes, endothelial, bone
marrow, thymic stromal and small cell lung cancer cells [117].
Moreover, SCF mRNAs (cDNAs) structure and expression have
been identified in a variety of other tissues such as brain, kidney,
lung, and placenta (source: Ensembl, Aceview). Perhaps one of the
more interesting improvements in the area of hair follicle
melanogenesis is the isolation of SCF. Although considerable
information on SCF cDNA sequences are available in the
GenBank repository (NCBI) for several mammal species, the
full-length mRNA (cDNA) structure for sheep (Ovis aries) remains
unclear untill now (source: Oarv2.0, GenBank, NCBI, March
2012). To our knowledge, there is no experimental evidence or
report for the existence of ovine SCF in skin. Taking into account
the potential role exerted by SCF in hair follicle melanogenesis
[16,36], ovine SCF cDNAs were amplified, cloned and sequenced
from the skin of white merino sheep (Figure 1 and 2). Nucleotide
sequence analyses and the deduced amino acid sequences disclose
the orthology of ovine SCF gene with other mammal species
(Figure 3 and 6(a); see also Figure S3(a-d)). Herein, we report for
the first time, the isolation of the two alternatively spliced, full-
length oSCF mRNA (cDNA) transcripts such as the longer, SCF
isoform-1 (+) widely known as ‘soluble or secreted’ (s-SCF) form and
a shorter, SCF truncated isoform-2a/b (2)( a/b denotes the 59 UTR
differences; see Figure S4(a1)) possibly characterized as the
‘membrane-anchored’ (m-SCF) form from the skin biopsies of
white merino sheep. In which, the later has been identified and
characterized as ‘novel’ in that the truncated (2) form reported in
this study is devoid of 28 aa proteolytic site including a N-linked
(GlcNAc) Glycosylation sites and the 23 aa transmembrane region
followed by the cytoplasmic tail corresponding to 35 aa in
comparison to the commonly known SCF (+) form
(Figure 5(a,b)). As a result of the premature termination codon
(PTC) in intron-5, the novel protein isoform has a unique,
truncated, short stretch containing ‘KTYKHS’ (6 aa) as its novel
C-terminus (Figure 6(c,d) and Figure S3(b,c); see also Figure S1B).
It has been proposed that soluble SCF is derived from the
transmembrane form by proteolytic cleavage within its extracel-
lular domain [25].
The primary oSCF cDNA fragment (621 bp; Figure S1A,B)
corresponding to the CDS of 606 bp reported here closely
matches to the previously described oSCF sequences [118,119].
The only exception in the deduced 202 aa is at Q
134 (glutamine)
which has been reported as E
134 (glutamic acid) [118]. However, it
has been confirmed as Q
134 in our virtual translation from the
sequenced oSCF cDNA sequences (in this study) and is in
agreement with the previously reported oSCF [119]. Besides, the
bovine SCF amino acid sequence also has a Q at pos. 134 [98]
(Figure S3(d)). In the present study, the coding region of the
longer, oSCF (+) form is identical to that of previously isolated
human SCF (Figure 5(a)) and corresponds to the other mammalian
counterpart of SCF (+) form (Figure S6(a,b)). In contrast, the
shorter oSCF (2) form identified in the present study, has
a premature termination codon (PTC) at intron-5 (Figure S4(b))
leading to the complete skipping of exon 6 to exon 9/10 viz.
differing in the cassette exon (CE 6–9/10). Since this splicing event
leads to complete elimination of the proteolytic site, a trans-
membrane region and the subsequent cytoplasmic domain of the
oSCF (+) protein (Figure 5(a,b)), the resultant product of the
shorter isoform would not be secreted (Figure 5(c)). Perhaps,
the cell would require an alternative mechanism for producing this
shorter isoform. At this stage, it is important to examine which cell
type (melanocyte, keratinocyte and fibroblast) is producing this
truncated oSCF (2) form and where it is expressed either
intracellular or extracellular environment (Figure 5(c)) will
elucidate the functional and biological significance of this oSCF
(2) product in hair follicle melanogenesis. In comparison to the
previously reported 245 aa membrane-bound isoforms in other
mammals [5,6,25,136], it is possible that the SCF encoded by this
shorter ovine cDNA would remain membrane-bound as it lacks
the necessary primary proteolytic cleavage site to produce a soluble
form [25]. This form of SCF mRNA thus can produce only
membrane-anchored SCF [6,25,120]. While the in vivo roles of
soluble versus membrane-bound SCF are unclear, like other
membrane-associated growth factors (e.g. Transforming growth
factor, TGF-a and Tumour necrosis factor, TNF), is thought to be
involved in intercellular communication [10].
Over all sequencing results revealed that the SCF gene like in
other mammal species, oSCF primary transcripts also undergo
alternative splicing (Figure 3(c,d)) with the exon-intron boundary
location, size and amino acid composition of the alternatively
spliced region being highly conserved [5,6,97,98]. Alternate
splicing of intron-5 (CE 6–9/10; skipping of exons 6–9/10) of
SCF might therefore provide a mechanism by which the specific
type of cell (melanocyte, keratinocyte and fibroblast) could regulate
the relative amounts of soluble and membrane-bound SCF that
were produced inside the cell (Figure 5(c)). In addition, to the
known variant lacking exon 6, an alternative splicing of exon 4,
resulting in four possible isoforms was reported in pig [121].
Analysis of oSCF to human, mouse, rat and dog genomic clones
showed identical exon/intron boundaries of the oSCF gene
architecture (Figure 3(a,b,e,f); see also Figure S2). While perform-
ing oSCF cDNA amplification including 59 and 39 RACE, we
have analyzed a number of independent oSCF clones and have
found no evidence for an alternatively spliced form encoding
a membrane-anchored isoform corresponding to the 245 aa as
reported in other vertebrate species [5,6,100,122]. From our RT-
PCR results, it seems that this particular mRNA species is
completely absent in sheep atleast in skin. In other words, the
spliceosomal machinery in the skin of sheep failed to generate the
oSCF mRNA (2) form which encode for the 245 aa. Instead, it
generates the above described truncated shorter ovine m-SCF (2)
form (Figure 3(d)). Henceforth, we assume that spliceosomal
machinery eliminates the probability of SCF mRNA(s) processing
in a similar manner across species i.e., the retention of exon 7 to
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has been reported in several studies [5,6,100,122].
The original descriptions of the cloning of SCF including
location of introns in the coding regions have been reported for
human and rat SCF genes [100]. In comparison to other
vertebrate species, the SCF gene is composed of at least 9/10
exons (Figure 3; see also Figure S2) ranging from ,63 bp to
,4 kb in length which are intervened with a wide range of varying
length of 8/9 introns viz. ,700 bp to ,34 kb (source: Ensembl).
The locations of introns in the coding region of SCF are conserved
in rats, mice, and humans [5,100]. The total length of SCF gene
ranges between ,72 kb to ,87 kb (source: Ensembl). Previous
reports on oSCF Northern blot analysis revealed a major SCF
mRNA transcript of ,6 to 6.5 kb in ovarian follicles, corpus
luteum and stroma [118,119]. In other species, a major band
between 5.5 and 6.5 kb has been described in human [100],
mouse [5,11], cow [98], pig [101] and chicken [103]. Shorter and
less abundant SCF mRNA species have been reported in the
mouse [5] and the chicken [103] (source: Ensembl). From our
Northern blot ananlysis and long range 39 RACE RT-PCR, it
seems that the larger SCF transcript (,6 kb) is not expressed in
ovine skin.
The human and mouse SCF gene on AceView program [89]
revealed 18 different ‘GT-AG’ introns and the transcription
produces 8 different mRNAs (Figure S2 and Table S3A), 7
alternatively spliced variants and 1 unspliced form. There exist 2
probable alternative promotors, 2 non overlapping alternative last
exons and 5 validated alternative polyadenylation sites (Table
S3C). The mRNAs appear to differ by truncation of the 59 end,
truncation of the 39 end, presence or absence of 9 cassette exons,
overlapping exons with different boundaries (Table S3B). The
corresponding protein coding potential resulted in 7 different
complete isoforms (coding for proteins; Table S3D) from the 6
spliced and one unspliced mRNAs. The remaining left over
mRNA variant (spliced) appears not to encode for a protein (non-
coding). Similar structural features have also been documented
(data not shown) at ASTD 1.1 [90]. According to AceView, this
gene is expressed at high level in a wide range of tissues (Table
S3B) revealing its heterogeneity of SCF expression, for example in
human placental tissue, five SCF mRNA transcripts were detected
[123] by RT-PCR, and that they appear to be under tissue-specific
regulation whereas only one transcript size was detected in porcine
endometrial total cellular RNA (tcRNA) [101].
In human, exon 1 (198 bp) is organized into 183 bp as 59 UTR
sequences and the last 15 bp including the initiation codon ‘ATG’
encode for the first 5 aa of the putative 25 aa signal peptide. Exons
2–7 encode portions of the extracellular domain of the SCF and
exon 7 encodes the transmembrane region. While exon 8 encodes
35/36 aa of the cytoplasmic tail, the stop codon, and part or all of
the very long ,4.4 kb 39 UTR (exon 9/10) of the SCF mRNA
transcript [100]. As noted previously, SCF can exists as two
alternative mRNA transcripts that have been identified for the
presence (+) or absence (2) of the 84 nt sequences encoding the
proteolytic cleavage site relative to the full-length SCF cDNA
[5,6,25,100]. Based on this SCF has been basically classified into
variant-1 (+) and variant-2 (2) which are encoding for the protein
273 or 274 aa and 245 aa, respectively. The end points of the
missing sequence correspond to the boundaries of exon 6 reported
for the rat and human SCF genes [100]. This spliced feature is
commonly seen in almost all vertebrate species (source: Ensembl).
In murine, SCF cDNA (MGF94), the deletion in the second
variant is smaller (48 bp) but shares the same 59 boundary [5], this
might be a due to different exon/intron structure for the mouse
SCF (MGF) gene, or different alternative splicing within exon 6
that may have occurred during mRNA processing [97]. After
analyzing the exon 5-intron (5)-exon 6 boundaries, it is certain that
these transcripts are derived from the use of alternative 39 splice
donor/acceptor sites in the precursor mRNAs. The exon 6 region
encoding for the 28 aa proteolytic site of oSCF is absolutely
conserved (100% except for marmoset which has 92% identity)
among the reported vertebrate SCF sequences (Figure 6(d); see
also Figure S3(b)), suggesting a functional importance of this
region of the molecule. However, avian species which has an
additional 6 aa ‘SIGSNT’ (Figure S3(b) in a total of 34 aa shows
75% identity to its counterpart of 28 aa proteolytic site of other
SCF (+) mRNA species. At this junction, fish has only 10–17%
identity, revealing its long distance of evolutionary conservation
for adaptation.
Scanning SCF gene through various genomes such as cow chr 5
(Btau_5.2, ENSBTAG00000017549); pig chr 5 (Sscrofa9,
ENSSSCG00000000922); dog chr 15 (CanFam2.0, EN-
SCAFG00000006091); horse chr 28 (EquCab2, ENSE-
CAG00000000152); human chr 12 (GRCh37,
ENSG00000049130); chimpanzee chr 12 (CHIMP2.1,
ENSPTRG00000005281); orangutan chr 12 (PPYG2, EN-
SPPYG00000004816); marmoset chr 9 (C_jacchus3.2.1, EN-
SCJAG00000019661); alpaca scaffold_157 (vicPac1, EN-
SVPAG00000006812); mouse chr 10 (m37,
ENSMUSG00000019966); rat chr 7 (RGSC3.4, EN-
SRNOG00000005386); rabbit chr scaffold_18 (oryCun2, ENSO-
CUG00000017687); chicken chr1 (WASHUC2, EN-
SGALG00000011206); zebra finch chr 1A (Tae_Gut3.2.4,
ENSTGUG00000008039); and zebra fish chr 25 (Zv8, EN-
SDARG00000070917 and ENSDARG00000058042), showed the
overall expected size of SCF mRNA/cDNA for the (+) and (2)
form ranging between 1.5 kb to 5.6 kb from cow, horse, dog, cat,
pig to goat, human, mouse and rat. Of which the 39 UTR
sequence alone ranges between 490 bp to 4.4 kb. The longest
,4.4 kb 39 UTR mostly reported in brain, placenta, prostate,
ovary and hematopoietic stem cells (source: GenBank, NCBI).
Taking all the above into consideration, we have performed the 39
RACE with high Tm primers, with or without DMSO in order to
denature the suspected secondary structure [46] of the cDNAs and
to enhance the target amplification. We also checked the presence
of a wide range of SCF 39 UTR amplicons up to 5 kb by
performing a two-step PCR with a coupled annealing and
extension time up to 10 min. We did not obtain the expected
longer ,4.4 kb as of different trials of 39 RACE PCR
amplification which inturn excluded the presence of such long 39
UTR transcript variant (as in case of other mammals:
AB002152.1, brain, goat; NM_000899.3, NM_003994.4,
CR749222.1, Ref.Seq. annotated, human; XM_509255.2, Re-
f.Seq. annotated, chimpanzee; NM_013598.2, Ref.Seq. annotat-
ed, mouse; NM_021843.3, NM_021844.1, Ref.Seq. annotated,
rat) in the skin of sheep. From the available database sequences
and reports, we observe that the longest 39 UTR is expressed in
a tissue or cell type specific manner for the stable expression of
SCF. Furthermore, the existence of such long 39 UTR enhances
the SCF mRNA structural stability and thereby regulates SCF
expression (by miRNAs) which is required by the specific type of
cell for its biological function [5,124].
Overall, it was determined that the longer ovine s-SCF isoform-1
(+) of 1519 nt which would encode for a larger secreted protein
product of 274 aa (Figure 5(a)). This longer transcript has an
insertion of 84 bp at nt. pos. 713–796 by an AS event
corresponding to the 28 aa putative proteolytic cleavage site.
Similarly, the novel, shorter ovine m-SCF isoform-2a/2b (2)o f
835/725 nt (named in respect to the 59 UTR differences; Figure
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anchored protein product of 181 aa, which lacks the proteolytic
site (Figure 5(b)). The mRNA/cDNA structural coverage of oSCF
is shown in Figure 1A,B. The nucleotides and subsequent deduced
amino acid sequences of the ovine SCF isoform (+/2, complete)
has high % identity with other mammalian SCF species
(Figure 6(a)). The longer and shorter oSCF cDNAs has 85–
100% identity to the kit ligand ESTs which are deposited in mouse
(DV046036.1, DV044494.1, DT909652.1) and human
(DR005930.1, DR002356.1, BX474960.1, DC320486.1) especial-
ly in brain, prostate and hematopoietic stem cells but not in skin.
In comparison to the previous submitted records, GenBank Acc.
No. AAB49491.1 and the Swiss-Prot ID. P79368.2, our ovine s-
SCF (+) form (GU386372; see Table S1) encoding for a total of
274 aa (Figure 5(a)), has an additional 7 aa i.e., ‘EREFQEV’ at its
C-terminus (Figure S1B). Also, it differs from the Acc. No.
CAA90620.1 with an additional 72 aa right after the proteolytic
site, towards the C-terminus. Conversely, the alternatively spliced
truncated transcript of ovine m-SCF (2) form (GU386373,
GU386374 and GU386371; see Table S1) reported in this study
has been recognized as novel, with a new additional 6 aa residues
i.e., ‘KTYKHS’ as its C-terminus (Figure 6(c); see also Figure S1B
and S3(c)), right after D
175G. This ovine m-SCF (2) form
completely lacks the proteolytic site, a transmmebrane region and
the cytoplasmic tail (Figure 5(b)), in contrast to the 245 aa SCF (2)
form that has been widely reported in other mammal species. Both
soluble and transmembrane forms of SCF are active in promoting
mast cell proliferation [5,122]. However, the transmembrane form
appears to be more potent in maintaining the viability of
primordial germ cells in vitro [125]. Mice that produce the soluble
SCF (s-SCF) but not transmembrane SCF (m-SCF) suffer from
anemia, lack pigmentation and are sterile [126]. This suggests that
transmembrane SCF plays a special role in vivo that is separate
from that of soluble SCF. Hence, the presence of both soluble and
transmembrane SCF is required for the normal biological
function. The proteolytic processing can also occur in mouse
SCF at a secondary site at or near the tetra-peptide ‘KAAK’ in
exon 7 [10]. This secondary proteolytic cleavage site appears to be
species-specific as in case of human there is an amino acid
sequence divergence in this (‘KAKN’) region directing no protein
processing [10]. The oSCF may also lack this secondary processing
site as the amino acid sequence differs by ‘KASN’ from the mouse
in that region (Figure S3(d)).
The ovine s-SCF (+) isoform-1 specific 59 RACE amplification
(Figure 1A(c)) yielded a 364 bp amplicon with its isoform specific
primer pair (Table S2) which is highly conserved among other
mammals (Figure S4(a2)). Conversely, the common CDS region
(+/2) primers (Table S2) yielded two different amplicon of sizes
325 bp and 215 bp (Figure 1B(d)) for the 59 RACE RT-PCR
which are subsequently differentiated by their 59 UTR differences
(Figure S4(a1)) and characterized as ovine m-SCF (2) isoform-2a/
2b, respectively (in this study). All three 59 RACE amplicons differ
by their length for the (+) and (2) form as shown in Figure S4(a1).
Owing to its high G+C content (65%; Figure S4(a3)), sheep SCF
mRNAs has the potential to form compact, thermodynamically
stable secondary structures (Figure 8(a,b)), due to the third
hydrogen bond in G–C pairs compared to A–U pairs, and the
ability of guanine residues to interact with uracil in folded RNA
[127]. Henceforth, it favors the amplification of minor oSCF 59
RACE cDNA products (in our case, iso-2b (2); Figure S4(a1)). The
elevated G+C content is predicted to affect folding of the cDNA
templates, compromising DNA polymerase processivity [111].
G+C sequence bias is a well known problem in cDNA profiling
studies [128]. This is not only because of the fall out of Taq DNA
polymerase during PCR, also at certain level of reverse transcription
by reverse transcriptase since our sequenced individual clones of
all three 59 RACE products (+/2) has the complete 59 adapter
forward primer sequences complementary to the 59 end capping
(C-tail). The GC-rich non-coding 59 segment of SCF forms a dense
secondary structure (Figure 8(a,b)) that may have the consequences
for oSCF protein expression. For example, translation may require
specific mRNA unwinding activity, creating another mode of
possible post-transcriptional regulation [129]. Furthermore,
mRNA hairpin structures are known to obstruct ribosome
elongation [130] and G+C content is inversely correlated with
translation efficiency [131].
Apart from the classical 273 or 274 aa SCF starting with
‘MKK’ as its N-terminus sequences, there are a number
alternatively spliced protein/peptide sequences do exists for
SCF, resulting in a unique or skipped N-terminus sequences such
as, N-terminus starting with ‘MPSCLAAQ’ (protein:
CAH18078.1, peptide: ENSPTRP00000050003, EN-
SCJAP00000036530: 238 aa) in human, chimpanzee and mar-
moset, respectively; ‘LFKTL’ (peptide: ENSCJAP00000036543:
273 aa) in marmoset; ‘LLKTL’ (peptide: ENSP00000349630,
ENSPTRP00000045663: 273 aa); ‘TWII’ (peptide: ENSE-
CAP00000000163, ENSCAFP00000009149: 269 aa) in horse,
dog, respectively; ‘LLFN’ (protein: AAM16280.1: 258aa) in dog;
‘LQPS’ in cow (peptide: ENSBTAP00000023349: 212 aa);
‘ICRNR’ (peptide: ENSSSCP00000000985: 177 aa) and ‘TWIIT’
(peptide: ENSSSCP00000000986: 38 aa) in pig; ‘KKKE’ (peptide:
ENSRNOT00000008471: 272 aa) in rat and ‘IITC’ (protein:
AAB49491.1: 260 aa) for sheep. In mouse, SCF has 6 to 9
different GenBank/Ensembl records with the minimum of peptide
containing 123 aa residues up to protein of 273 aa residues
including an unique N-terminus sequence of ‘NRTE’ (peptide:
ENSMUSP00000100919, ENSMUSP00000100918). This kind of
alternatively spliced N-terminus do exists even in birds and fishes
i.e., ‘FFTKQ’ (peptide: ENSTGUP00000008290: 287 aa) in
zebra finch; ‘GNPV’ (protein: ABI98396.1: 264 aa and
ABI98398.1: 164 aa) in chicken; ‘MTGF’ (protein:
XP_002666882.1: 292 aa) and ‘IWIC’, ‘MFHM’ (peptide: EN-
SDARP00000101828, XP_682759.2: 267 aa) in zebra fish. The
above collective details are obtained from Ensembl and GenBank,
NCBI.
Consistent with the already reported and submitted SCF
sequences, oSCF gene consists of 9/10 exons separated by 8/9
introns (Figure 3(e,f)). Exon sizes correlate well with those reported
for the human, mouse and dog (source: GenBank, Ensembl). From
the gDNA spliceosomal intron-5 amplification, the premature
termination could be explained by the use of an alternative
isoform/cryptic 59 donor site at nt pos. 218 (GT, Figure 6(b) and
S4(b); right after 57 nt of the p(A)11) and a constitutive 39 acceptor
(AG) at nt pos. 728 (just before the start of exon 6) or the one at nt
pos. 350 recognised by the transcription machinary (Spliceosome)
and/or the lack (?) of any consensus 39 splice site sequence
downstream of exon 6 to exon 9/10 prevents the removal of the
161 nt intronic sequences which is present in the shorter cDNA
(Figure 2(a,b) and S4(c)). The retaining of 161 bp noncoding DNA
(intron-5) sequences in the truncated shorter m-SCF (2) cDNA
might have arisen from failure of the transcription machinary to
correctly remove the intronic sequence from the skin oSCF
mRNA transcript. Though the chromosomal number was de-
termined in sheep (chr 3) [105], it was observed that the sheep
SCF locus is yet to be mapped (see Figure 4), depicting its
unfinished status of the Sheep Genome Project at this juncture
(current version Oarv2.0, March 2011 - till date, http://www.
livestockgenomics.csiro.au/sheep/oar2.0.php). The mechanism
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truncated oSCF mRNA could have been generated in the normal
skin and adds to the list of variants of the SCF gene that undergo
alternative splicing (AS).
Previous studies have shown that skin expression of SCF
stimulates melanocyte migration, proliferation, differentiation, and
survival and is required for ongoing maintenance and survival of
normal melanocyte numbers in adults [132]. SCF (KL) upstream
region is associated with significant differences in human skin
color, one of the most obvious superficial differences between
human populations [133]. Although no amino acid differences are
known in the SCF (KL) protein of different human groups, SCF is
expressed at significantly higher levels in skin keratinocytes from
Africans than Europeans [134]. The interruption of SCF–KIT
signalling using anti-KIT antibody abolished tyrosinase and MITF
expression, resulting in the depigmentation of hair follicles in
a reversible manner [16].
The preliminary analysis of oSCF gene expression in skin,
showed similar mRNA (cDNA) expression profile between (+) and
(2) form among white and coloured animals (data not shown).
Our result was in agreement with porcine SCF (KL) gene
expression for exon 6 [121]. However, this would require
verification via more sensitive qRT-PCR methods on reasonable
number of breeding populations i.e., F2 generations. Conversely,
Northern blot analysis (Figure 7) revealed considerable difference
between oSCF (+) and (2) form providing a hypothetical clue on
transcription regulation via an intron-5 AS event. Different
biological activity have been reported between the membrane
anchored (2) and the soluble forms (+) of SCF [9,11]. In 1999, Dr.
James M. Grichnik, wrote in his reply to [135] ‘‘While both forms of
SCF activate its receptor, KIT, the duration of activation and potential for
receptor degradation is different for each form. Keratinocytic bound SCF may
lock on to the melanocyte’s KIT receptor resulting in persistent KIT activation
(without KIT receptor internalization and degradation), while soluble SCF
may transiently activate the KIT receptor followed by internalization and
degradation’’. This implies that the membrane-bound steel factor
induces more persistent tyrosine kinase activation and longer life
span of c-KIT gene-encoded protein than its soluble form. More
sustained signaling was mediated by membrane associated SCF in
a myeloid cell line where as the soluble SCF down regulates cell
surface expression of c-KIT and promotes receptor proteolysis
[136]. The differential expression of SCF-specific mRNA splice
variants, SCF-1 and SCF-2 in immature and mature human mast
cells may play a role in autocrine stimulation, maintenance of
survival and the differentiation of tissue mast cells [137]. An
increased level of soluble SCF expression in the skin has been
implicated in the pathogenesis of mastocytosis that could
theoretically be due to the abnormality at any level of metabolism
occurring after the mRNA transcription and splicing rather than
the result of changes in the sequence or regulation of the gene itself
[19]. Hence, further investigation regarding sheep skin SCF gene
expression is required at cellular level rather than at tissue basal
level. The possible functional role of these two oSCF isoforms in
skin remains poorly understood. According to AceView [89] gene
expressinon analyses, SCF is defined by 198 GenBank accessions
from 192 cDNA clones, some from brain (seen 14 times), trachea
(13), placenta (9), thalamus (7), whole brain (7), lung (6), amygdala
(5) and 61 other tissues excluding skin. Molecular biological
analyses of murine follicular skin indicated a significant increase of
membrane-bound SCF expression [16], after anagen induction in
concert with the escalation of cutaneous tyrosinase activity and
corresponding pigmentation.
Eukaryotic splicing produces a variety of functional and
nonproductive mRNAs during normal gene expression [138].
While alternative splicing greatly enhances recurrent errors that
include exon skipping, intron retention, and activation of cryptic
splice sites [138]. The resulting aberrant RNAs may outnumber
correctly spliced mRNAs among initial spliceosomal products
[139]. This could be one of the reason for the oSCF (2) form to be
present predominant over (+) form during the reverse transcription
reaction (RT) and its subsequent PCR amplification. For protein-
coding genes with multiple exons, the majority of aberrant RNAs
contain a premature truncation codon (PTC; in our case, the
shorter ovine m-SCF (2) form) which are frequently produced in
mammals are known to be degraded through the nonsense-
mediated decay (NMD) pathway [140]. However, the abundance
of full length oSCF (2) mRNA transcripts in the skin of sheep
argues against such degradation.
Control of gene expression is achieved at various levels. The cis-
regulatory elements, uORFs (in + and - form) and TOP (in + form)
detected on the 59 UTR of oSCF just upstream to the AUG
initiation codon (Figure S4(a1)) are known to be involved in the
translation down regulation. The uORFs can induce formation of
a translation-competent ribosome that may translate and (i)
terminate and re-initiate, (ii) terminate and leave the mRNA,
resulting in down-regulation of translation of the main open
reading frame, or (iii) synthesize an N-terminally extended protein
[108]. The 59 TOP tract consisting of 5–15 pyrimidines that is
required for coordinate translational repression during growth
arrest, differentiation, development and certain drug treatments
[141]. Deletion of the pyrimidine tract or exchanging purines for
pyrimidines results in unregulated translation [109,141]. In our
case, we observed the deletion of TOP sites in the two shorter 59
UTRs of oSCF-2a/2b (2) form (Figure S4(a1)). Regarding the 39
UTR cis-regulatory sequences such as AREs (PAS) [110], BRD-
Box [111] and MBE [112] mediates negative post-transcriptional
regulation by affecting mRNA transcript stability and translational
efficiency [110,140]. In our case, the 39 cis-regulatory signals,
BRD-Box and MBE, located upstream and downstream PAS
(Figure S4(d,c)) may regulate tissue-specific alternative polyadeny-
lation which has been detected in approximately 54% of human
genes [142]. The exact role of the conserved miRNA target sites
(Figure 9(a,b)) in SCF is currently unknown, although this
conservation in other farm animals (71–100%) suggests functional
importance (evolutionary pigmentation adaptation). On the other
hand, various miRNA target sites in the longer 39 UTR (data not
shown) might signify that the mRNA is regulated specifically in
different tissues or at different times during development. The
potential role of miRNAs in SCF gene regulation is currently
unidentified in particular for hair follicle melanogenesis.
SCF is a member of the helical cytokine structural super-family
characterized by a double crossover four-helix bundle topology
[143]. The N-terminal 141 residues of SCF have been identified as
a functional core, SCF
12141, which includes the dimer interface
and portions that bind and activate its receptor, c-kit [112]. The
homology-based structural modeling results showed that the
protomer structure of oSCF contained 4 a-helices and 2 b-sheets
that were folded to form the non-covalent homodimer composed




164 (Figure S5) plays a role
in maintaining the functional integrity of SCF [143] and are highly
conserved in mammals except for fishes where it is replaced with
Ile
27/His
107 (Figure S3(d)). The available PDB crystallographic
models for SCF proteins such as 1EXZ, 1SCF and 2E9W:chain C,
D [112–114] share the same canonical fold. The superimposition
of our modelled structure(s) to the individual templates revealed
identical structural features as described in [112]. The folding
differs in some regions from the above mentioned models with an
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previously determined crystal structure 2E9W, demonstrates the
interaction between SCF and its receptor, c-KIT [114]. In which,
each protomer of SCF binds exclusively to a single KIT molecule
and that receptor dimerization is driven by SCF dimers that
facilitate additional receptor-receptor interactions. Dimerization of
KIT is driven by bivalent SCF binding whose sole function is to
bind SCF and to bring together two KIT molecules [114]. The
three potential binding region of SCF i.e., site I, II, III for its
receptor, c-KIT has been well explained in [114] and the same are
shown in Figure S5 (see also Figure S3(d)). There are notable
differences found in the interacting residues of KIT and SCF
[114]. Mutational analysis of SCF has shown that replacement of
Asn
35 with alanine or glutamic-acid residue, reduces the binding
affinity of SCF towards KIT by approximately 10-fold and Asn
35
(in human, chimpanzee and marmoset) or Asp
35 (in other species)
is required for the biological activity [144]. ClustalW comparison
(Figure S3(d)) of the receptor-binding interface in SCF from
different species shows the high conservation for Asn
35,36 in
human, chimpanzee, marmoset or Asp
35,36 in sheep, goat, cow,
pig, dog, panda, cat, horse, chicken, zebra finch, zebra fish and
gold fish and Asp
35, Asn
36 in mouse, rat and rabbit (Figure S5).
Similarly, Asp
79 of SCF in human, chimpanzee is substituted by
a Leu
79 in mouse or Val
79 in sheep, goat, cow, pig, dog, panda,
cat, horse, rabbit, rat, zebra fish and gold fish or Ser
79 in
marmoset, chicken and zebra finch. Besides, Lys
106 in sheep, goat,
cow, pig, dog, panda, cat, horse, mouse, rat and rabbit is
substituted by Asn
106 or Arg
106 in human, chimpanzee, marmoset
and chicken, zebra finch respectively. In addition, Glu
113 of SCF
in sheep, goat, cow, pig, dog, panda, cat, horse, rabbit, human,
chimpanzee, marmoset, is substituted for by Leu
113 and Ala
113
residues in mouse and rat, chicken, zebra finch, respectively.
Similarly, Phe
127 (loss of a hydrogen bond) in human, chimpanzee,
marmoset is substituted with Ser
127 in sheep, goat, cow, pig, cat
and rabbit which is quite common in protein fucntional centres,
most likely able to form a hydrogen bond. All these substitutions
(Figure S3(d)) involved in salt bridges, hydrogen and van-der-
Waals bonding may account for the reduced affinity of SCF
towards its receptor, c-KIT [145].
SCF (KITLG) was found not only in the mammal species such
as sheep, goat, cow, pig, cat, dog, panda, horse, human,
chimpanzee, marmoset, mouse, rat, and rabbit but also in avian
such as chicken, zebra finch and fishes, such as zebra fish, gold
fish, indicating that it had the co-emergence with huge divergence
across species (Figure S6(a-e)). The enormous evolutionary
distance on the phylogentic tree (branch length) indicate the low
sequence identity of the fish (Figure 6(a); see also Figure S3(d))
species to the other mammal species ranging between ,20–55%
for the SCF (+) and (2) protein sequences which implies SCF
evolutionary changes may make it as monophyletic group(s) for
more pigmentation adaptation in a wide range of habitats. One
such example is that, the cis-regulatory (UTRs) changes in SCF
(KL) expression contribute to pigmentation differences in both
sticklebacks and humans suggesting its contribution to natural
variation in vertebrate pigmentation and those similar genetic
mechanisms may underlie rapid evolutionary change in stickle-
backs and humans to rapidly evolve changes in pigmentation
patterns [146]. The little skate in the tree topologies (Figure S6(a-
e)) especially those nodes showing ,60% bootstrap values viz.
horse to dog; mouse, rat to rabbit; and rabbit to primates are most
likely reflects the use of incomplete SCF sequences from the gene/
genome databank (partial sequences, unfinished genomes) or due
to the use of unwanted gaps in the alignment or could be the huge
sequence divergence at certain level in the block analyzed in the
present study.
Conclusion
The study that we describe here represents the first attempt to
experimentally address the SCF mRNA/cDNA structural cover-
age in the skin of merino sheep. The analysis of coat color gene(s)
structure unique to sheep will extend our understanding of the
functional role and regulation of pigmentation genes beyond what
was known in mice, humans and other mammals. Here, we have
presented evidence for two splice variants of ovine SCF, differing
in the cassette exon (CE 6–9/10; skipping of exons 6–9/10) by
a premature termination in the non-coding intron 5, which
resulted in the presence or absence of a proteolytic site and there
by the following transmembrane region and cytoplasmic domain.
To our knowledge, this information is previously unreported.
Further research is required to determine whether this premature
terminated isoform has biological relevance, and whether it leads
to the active variant proteins with effects on melanocytic,
reproductive or haematological development. The functional role
of these two transcripts in ovine skin-specific expression remains
unknown. It is important to elucidate which SCF transcript(s),
either soluble-SCF (+) or membrane-SCF (2), predominate in the
skin which will provide a new insight into an elaborate mechanism
involving m-SCF/c-KIT and its counteracting s-SCF/c-KIT
signaling that will add to the understanding of the regulation of
SCF on hair follicle melanogenesis. In addition, characterization
of the SCF promoter(s) is also critical to the design of experiments
intended on analysis of the role of various SCF isoforms in vivo
using gene targeting techniques. Also, in connection to [33], it
would be interesting to determine whether any of the individuals
(white, black, and brown) in their families (F2 generation) have
alterations in the SCF gene expression at allele level (QTL/SNPs)
or it may have the other alternative splice variant(s)? or lacking any
particular reported SCF variants or duplication [147] and/or SCF
DNA rearrangement [148]. Future studies exploring other
candidate genes are underway especially those involved in the
pigmentation regulatory network namely c-KIT and MITF.
Altogether, these genes are likely to provide great insight into
our understanding of molecular mechanism of the white trait in
merino sheep. In this context, further developing ovine chip(s) with
key pigmentation associated genetic information such as c-KIT,
SCF, MITF, MC1R, ASIP and FGF etc., will open up promising
perspectives on using those molecular information in the
management of breeding schemes of sheep populations i.e.,
aiming at Gene Assisted Selection (GAS).
Supporting Information
Figure S1 SCF Multiple Sequence Alignments (MSA). (A)
Comparison of the primary RT-PCR product of 621 bp CDS
covering the putative primary proteolytic site of white, black and
brown animal (representative data from one of three animal is
shown). The start (ATG) codon is labeled in bold blue letters and
the +84 bp proteolytic site is indicated in bold black italic letters.
The virtual translation of 606 bp CDS corresponding to the
202 aa (in bold black letters) is given below to the ‘white’
nucleotide sequences; (B). Comparison of complete coding
sequence (CDS) and its corresponding deduced amino acid
sequence of the newly isolated Ovis aries SCF isoform-1 (+) and
isoform-2 (2) with the partial GenBank records of oSCF (+)
sequences. The newly identified oSCF cDNAs from the skin of
white merino sheep (GU386372 (+); GU386373 (2), see. Table
S1) are marked in bold black letters. While the other two oSCF
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GenBank, NCBI. Dotted black arrows indicate the corresponding
common forward primer ‘scffwd1’ and (+) form specific reverse
primer ‘scfrev1’ used to amplify the initial 621 bp (see also
Figure 1A(a)). The highlighted opened black box indicates the
flanking partial 59 UTR sequence (15 bp) of the forward primer
sequence (see. Table S2 and Figure 1A). The start (ATG) and stop
codons (TAA) are labeled in bold blue and bold red letters
respectively. The virtual translation of oSCF (+) and (2) forms are
given below to the respective triplet codons and highlighted in
bold black letters. The +84 bp putative primary proteolytic site
and its virtual translation (+28 aa) are indicated in bold black italic
letters. Similarly, the substitution of aspartic acid (D) with glutamic
acid (G) i.e., D(+)
175G(2) is indicated in bold light orange to bold
light green letters respectively (see the chromatogram of cDNA on
the left side). The new truncated protein isoform of oSCF (2) form
having a short stretch of 6 aa sequences as its C-terminus (in bold
black letters) is highlighted by opened green box. Two clone
differences are highlighted in bold red and bold light blue letters
(see the respective cDNA chromatograms given on left side).
(DOC)
Figure S2 AceView of human SCF (KITLG) gene en-
coded on minus strand of chromosome 12 (huchr 12).
Alternative mRNAs shown are aligned from 59 to 39 on a virtual
genome where introns (triangle lines in pink) have been shrunk to
a minimal length. Exon size is proportional to length (shaded and
opened square/rectangle pink boxes; see key to symbols), intron
height reflects the number of cDNA clones supporting each intron.
The mRNAs/cDNAs appear to differ by truncation of the 59 and
39 end and by the presence (+) or absence (2) of 84 bp insertion
for the proteolytic site (shaded in light green between exon 5/exon
6 on AceView variant b, a). In the above diagram, capped 59 ends
and aggregated 59 clones are indicated by shaded and opened
black tower pointers respectively. Similarly, validated 39 ends with
varying number of accessions (clones) are indicated by opened and
shaded blue, black tower pointers. Alternatively spliced (gt-ag)
introns are shaded with four different colours (light green,
lavender, light blue and light yellow).
(DOC)
Figure S3 Amino acid (aa) sequence conservation of
sheep SCF with other homologous vertebrate SCF. (a)
Conservation of the first 25 aa signal peptide of sheep SCF is
shown along with other species; (b), (c) Comparison of s-SCF and
m-SCF; (b) Highlights the conservation of the 28 aa proteolytic
site right after D
175 (in blue bold letters) is indicated in black bold
letters where in the additional 6 aa avian sequences are indicated
in red bold letters along with other aa substitutions indicated in
black bold letters; (c) The novel C-terminus end of sheep m-SCF
(in this study) right after G
175 (in red bold letters) is indicated in
green bold letters (final 6 aa sequences) and its alignment with
other predicted m-SCF C-terminus sequences are shown. In all the
cases, sheep SCF aa sequences are compared mainly with the
human SCF aa sequences, hence both are highlighted in black
bold letters; (d) The main alignment block showing topological
features of sheep s-SCF such as four a helices and two b sheets are
shown. In addition, ClustalW2 comparisons of the three potential
receptor (c-kit) interactive sites (Site I, II and III) in SCF from
different species [114] are shown. Sheep s-SCF orthologous
evolutionary aa substitutions are highlighted in black bold letters.
The four cysteine residues involved in disulfide bridges are
indicated in pink bold letters and the orthologous aa substitutions
in avian species are highlighted in red bold letters. An additional
aa residue at Glu(E)
155 in sheep s-SCF which differentiate it from
primates and rodents is highlighted in blue bold letters, which is
conserved in farm animals suggesting a functional importance of
this residue. Besides, the 28 aa proteolytic site, the putative
alternative proteolytic site, a tetra peptide [10] is indicated in black
bold letters.
(DOC)
Figure S4 Nucleotide sequence comparison of 59 and 39
untranslated regions (UTRs) of sheep SCF isoform-1 (+)
and isoform-2a/2b (2), the predicted UTR regulatory
motifs and the possible splice donor/acceptor sites on
intron-5 are shown. (a1) Sequence alignment shows sheep SCF
59 UTR length differences between isoform-1 (+) and isoform-2a/2b
(2). The additional sequences of 59 UTRs are indicated in green,
light orange and blue opened boxes for isoform-1 (+), isoform-2a (+)
and isoform-2b (2), respectively. The cis-regulatory elements
located in the the 59 UTR such as TOP and uORFs are labeled
and indicated in red opened boxes. The trinucleotide elements
such as ‘CGC’ and ‘TGC’ are highlighted in bold black letters and
by underline respectively. The hexamer direct repeats (DRs) are
labeled and indicated by opened boxes. Clone differences are
labeled in bold red to bold black letters; (a2) Alignment shows
SCF 59 UTR nucleotide sequence conservation of hexamer DRs
(in opened boxes) with other mammals; (a3) Histogram shows the
GC% of three different 59 UTR of sheep SCF; (b) The complete
sequence of sheep SCF intron-5 (729 bp) shows the constitutive
splice donor (GT, in bold blue upper case letters) site at the start
and the constitutive splice acceptor (AG, in bold red upper case
letters) site at the end. Other alternative isoform/cryptic splice
donor (gt), acceptor (ag) sites are labeled in blue, red lower case
letters respectively. The dinucleotide repeats, polyA stretch (p(A))
and predicted splice branch sites (BS, in green lower case letters)
are labeled and highlighted in opened boxes; (c) Nucleotide
sequence alignment shows 100% similarity of 39 UTR of isoform-2
(2) with 161 bp retained intron-5 of sheep SCF. The p(A) stretch
and the conservation of dinucleotide repeats flanked by two
tandem repeats (TRs) on either side of 39 UTR are marked in
opened boxes along with its counterpart sequences on intron-5 in
other animals; (d) Sequence alignment shows two different 39
UTRs of sheep SCF isoform-1 (+) and isoform-2 (2). The +84 bp
proteolytic site is indicated in bold black italic letters. The
common identical CDS just upstream to the proteolytic site are
indicated in opened box. The 39 UTR regulatory motifs such as
BRD, MBE and hepatamer DRs are labeled and highlighted with
opened boxes. In the above figure, the AREs located in the 39
UTR near by the canonical PAS are indicated by an underline
and the single base variants of its type is highlighted in blue letters.
Similarly, the start (ATG) and stop codons (TAA) are highlighted
in bold blue and bold red letters respectively.
(DOC)
Figure S5 Three-dimensional structure of oSCF mono-
mer generated by homology-based modelling represent-
ed by a ribbon diagram. Here the superimposition of oSCF
monomer to the PDB template 1EXZ:chainB (set to transparency)
is shown. The 4 a-helix, two antiparallel b-sheets, two additional
one-turn helix are labelled in blue (aA, aB, aC and aD), red (b1,
b2) and black (aB’, aD’) letters respectively. An exceptional
hairpin loop between aB and aC is shown in red dotted line. The
observed additional 3–4 turn helices are highlighted in green as G1
to G8 with the corresponding aa residues labeled respectively. The
three potential interactive sites of SCF for its receptor c-kit are
shown in bold letters as Site I, Site II and Site III [95]. In
comparison to human SCF, the highlighted aa residue in red at
Site I, II and III represents the orthologous substitution of aa
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164 are highlighted in pink.
(DOC)
Figure S6 Phylogenetic analysis of the two SCF isoforms
based on alignment of their complete nucleotide
sequences (CDS), deduced amino acid sequences, and
predicted DNA sequences representing exon(5)-intron-5-
exon(6) splice junction of SCF gene. Numbers on the
respective nodes denote percentages in the order of Neighbour-
Joining (NJ) using p-distance/Maximum likelihood (ML)/Bayesian
(BI) posterior probabilities. The values in the tree nodes represent
bootstrap values of 1000 trials, indicating the credibility of each
branch. Branch lengths are proportional to the number of amino
acid or nucleotide changes on the branch. (a) Phylogenetic tree
inferred from 17 soluble SCF (+) protein sequences; (b)
Phylogenetic tree inferred from 18 soluble SCF (+) nucleotide
sequences; (c) Phylogenetic tree inferred from 13 membrane-
bound SCF (2) predicted protein sequences; (d) Phylogenetic tree
inferred from 14 membrane-bound SCF (2) predicted nucleotide
sequences; (e) Phylogenetic tree inferred from 14 predicted DNA
sequences representing exon(5)-intron-5-6-exon(6) splice junction
(+/2) of SCF gene.
(DOC)
Table S1 GenBank Accession Nos. and description of
ovine SCF cDNAs submitted to NCBI.
(DOC)
Table S2 Details of Oligonucleotide primers used and
the corresponding experiment/target amplification of
ovine SCF isoforms.
(DOC)
Table S3 (A) Molecular annotation of mRNAs, the pre-
messenger or transcription unit, the 5 kb upstream and the UTRs
for SCF (KITLG; source: Aceview*). (B) Comprehensive details of
SCF mRNAs structure and different tissue expression (source:
AceView). (C) Details of the validated polyA sites of SCF (source:
AceView). (D) Details of the alternatively spliced, predicted SCF
protein properties (source: AceView).
(DOC)
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